京都大学医学部附属病院 放射線治療科

menu

業績集

2018 | 2017 |2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993

2018
  1. Aizawa R, Takayama K, Nakamura K, Inoue T, Kobayashi T, Akamatsu S, Yamasaki T, Ogawa O, Mizowaki T. Long-term outcomes of definitive external-beam radiotherapy for non-metastatic castration-resistant prostate cancer. Int J Clin Oncol. 2018; In press.
  2. Chen Z, Takehana K, Mizowaki T, Uto M, Ogura K, Sakanaka K, Arakawa Y, Mineharu Y, Miyabe Y, Mukumoto N, Miyamoto S, Hiraoka M. Five-year outcomes following hypofractionated stereotactic radiotherapy delivered in five fractions for acoustic neuromas: the mean cochlear dose may impact hearing preservation. Int J Clin Oncol. 2018; In press.
  3. Goto Y, Ashida R, Nakamura A, Itasaka S, Shibuya K, Akimoto M, Mukumoto N, Matsumoto S, Kanai M, Isoda H, Masui T, Kodama Y, Nakamura M, Takaori K, Mizowaki T, Hiraoka M. Clinical results of dynamic tumor tracking intensity-modulated radiotherapy with real-time monitoring for pancreatic cancers using a gimbal mounted linac. 2018; In press.
  4. Hamaji M, Mitsuyoshi T, Yoshizawa A, Sato T, Matsuo Y, Chen-Yoshikawa TF, Sonobe M, Mizowaki T, Date H. Salvage Pulmonary Metastasectomy for Local Relapse After Stereotactic Body Radiotherapy. Ann Thorac Surg. 2018;105:e165-e168.
  5. Hirashima H, Miyabe Y, Nakamura M, Mukumoto N, Mizowaki T, Hiraoka M. Quality assurance of geometric accuracy based on an electronic portal imaging device and log data analysis for Dynamic WaveArc irradiation. J Appl Clin Med Phys. 2018; In press.
  6. Hirashima H, Nakamura M, Ishihara Y, Mukumoto N, Akimoto M, Tomita T, Hirose Y, kitsuda K, Ishigaki T, Mizowaki T. Comparison of Gamma Pass Rate between the Dose-to-Water and Dose-to-Medium Reporting Modes for Patient-Specific QA Using a Helical Diode Array Dosimeter with a Fixed Phantom Density. Int J Med Phys Clin Eng Radiat Oncol. 2018;7:74-86.
  7. Hirashima H, Nakamura M, Miyabe Y, Uto M, Nakamura K, Mizowaki T. Monitoring of mechanical errors and their dosimetric impact throughout the course of non-coplanar continuous volumetric-modulated arc therapy. Radiat Oncol. 2018;13:1-8.
  8. Inoue T, Mizowaki T, Kabata D, Shintani A, Terada N, Yamasaki T, Negoro H, Kobayashi T, Nakamura K, Inokuchi H, Ogawa O. Recovery of Serum Testosterone Levels and Sexual Function in Patients Treated With Short-term Luteinizing Hormone-releasing Hormone Antagonist as a Neoadjuvant Therapy Before External Radiotherapy for Intermediate-risk Prostate Cancer: Preliminary Prospective Study. Clin Genitourin Cancer. 2018;16:135-141.
  9. Iramina H, Nakamura M, Iizuka Y, Mitsuyoshi T, Matsuo Y, Mizowaki T, Kanno I. Optimization of training periods for the estimation model of three-dimensional target positions using an external respiratory surrogate. Radiat Oncol. 2018; In press.
  10. Iramina H, Hamaguchi T, Nakamura M, Mizowaki T, Kanno I. Metal artifact reduction by filter-based dual-energy cone-beam computed tomography on a bench-top micro-CBCT system: concept and demonstration. J Radiat Res. 2018; In press.
  11. Iramina H, Nakamura M, Mizowaki T, Kanno I. Effective Atomic Number Measurement with Energy-Resolved Computed Tomography Using Two-Dimensional transXend Int J Med Phys Clin Eng Radiat Oncol. 2018;07:61-73.
  12. Ishida Y, Sakanaka K, Itasaka S, Nakamoto Y, Togashi K, Mizowaki T, Hiraoka M. Effect of long fasting on myocardial accumulation in 18F-fluorodeoxyglucose positron emission tomography after chemoradiotherapy for esophageal carcinoma. J Radiat Res. 2018;59(2):182-9.
  13. Katagiri T, Kobayashi M, Yoshimura M, Morinibu A, Itasaka S, Hiraoka M, et al. HIF-1 maintains a functional relationship between pancreatic cancer cells and stromal fibroblasts by upregulating expression and secretion of Sonic hedgehog. 2018;9:10525-10535.
  14. Matsuo Y. A promising result of locoregional tumor control with biologically adaptive radiotherapy in patients with locally advanced non-small cell lung cancer. Transl Lung Cancer Res. 2018;7:S111-S113.
  15. Matsuo Y, Mitsuyoshi T, Shintani T, Iizuka Y, Mizowaki T. Impact of low skeletal muscle mass on non-lung cancer mortality after stereotactic body radiotherapy for patients with stage I non-small cell lung cancer. J Geriatr Oncol. 2018; In press.
  16. Mitsuyoshi T, Matsuo Y, Itou H, Shintani T, Iizuka Y, Kim YH, Mizowaki T. Evaluation of a prognostic scoring system based on the systemic inflammatory and nutritional status of patients with locally advanced non-small-cell lung cancer treated with chemoradiotherapy. J Radiat Res. 2018;59:50-57.
  17. Mitsuyoshi T, Matsuo Y, Shintani T, Iizuka Y, Ueki N, Nakamura M, Mizowaki T. Pilot Study of the Safety and Efficacy of Dose Escalation in Stereotactic Body Radiotherapy for Peripheral Lung Tumors. Clin Lung Cancer. 2018;19:e287-e296.
  18. Nakamura M, Ishihara Y, Matsuo Y, Iizuka Y, Ueki N, Iramina H, Hirashima H, Mizowaki T. Quantification of the kV X-ray imaging dose during real-time tumor tracking and from three- and four-dimensional cone-beam computed tomography in lung cancer patients using a Monte Carlo simulation. J Radiat Res. 2018;59:173-181.
  19. Nakamura K, Mizowaki T, Inokuchi H, Ikeda I, Inoue T, Kamba T, et al. Decreased acute toxicities of intensity-modulated radiation therapy for localized prostate cancer with prostate-based versus bone-based image guidance. Int J Clin Oncol. 2018:23;158-164.
  20. Ono T, Miyabe Y, Takahashi K, Akimoto M, Mukumoto N, Ishihara Y, Nakamura M, Mizowaki T, Hiraoka M. Geometric and dosimetric accuracy of dynamic tumor tracking during volumetric-modulated arc therapy using a gimbal mounted linac. Radiother Oncol. 2018; In press.
  21. Ono T, Miyabe Y, Akimoto M, Mukumoto N, Ishihara Y, Nakamura M, mizowaki T. Development of a portable quality control application using a tablet-type electronic device. Med Phys. 2018;45:1029-1035.
  22. Ono Y, Yoshimura M, Hirata K, Ono T, Hirashima H, Mukumoto N, Nakamura M, Inoue M, Hiraoka M, Mizowaki T. Dosimetric advantages afforded by a new irradiation technique, Dynamic WaveArc, used for accelerated partial breast irradiation. Physica Medica. 2018;48:103-110.
  23. Sakanaka K, Ishida Y, Fujii K, Itasaka S, Miyamoto S, Horimatsu T, Muto M, Mizowaki T. Long-term outcome of definitive radiotherapy for cervical esophageal squamous cell carcinoma. Radiat Oncol. 2018;13:1-7.
  24. Sasaki M, Nakamura M, Mukumoto N, Nakata M, Hiraoka M. Dosimetric impact of translational and rotational setup errors for spine stereotactic body radiotherapy: A phantom study. Med Dosim. 2018; In press.
  25. Shintani T, Matsuo Y, Iizuka Y, Mitsuyoshi T, Mizowaki T. A Retrospective Long-term Follow-up Study of Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer From a Single Institution: Incidence of Late Local Recurrence. Int J Radiat Oncol Biol Phys. 2018;100:1228-1236.
  26. Uto M, Mizowaki T, Ogura K, Mukumoto N, Katagiri T, Takehana K, Hiraoka M. Dosimetric comparison between dual-isocentric dynamic conformal arc therapy and monoisocentric volumetric-modulated arc therapy for two large brain metastases. J Radiat Res. 2018; In press.

 

2017
  1. Aizawa R, Matsumoto S, Uneno Y, Nishikawa Y, Ozaki Y, Mori Y, Kanai M, Ishida Y, Sakanaka K, Hiraoka M. Severe esophagitis associated with cytomegalovirus during concurrent chemoradiotherapy for esophageal cancer. Jap J Clin Oncol. 2017;47: 885-888.
  2. Aizawa R, Sakamoto M, Orito N, Kono M, Ogura M, Negoro Y, Sagoh T, Tsukahara K, Komatsu K, Noguchi M. The Use of External-beam Radiotherapy for Muscle-invasive Bladder Cancer in Elderly or Medically-fragile Patients. Anticancer Res. 2017;37:5761-5766.
  3. Akimoto M, Nakamura M, Nakamura A, Mukumoto N, Kishi T, Goto Y, Mizowaki T, Hiraoka M. Inter-and intrafractional variation in the three-dimensional positions of pancreatic tumors due to respiration under real-time monitoring. Int J Radiat Oncol Biol Phys. 2017;98:1204-1211.
  4. Goto Y, Koyasu S, Kobayashi M, Harada H. The emerging roles of the ubiquitination/deubiquitination system in tumor radioresistance regarding DNA damage responses, cell cycle regulation, hypoxic responses, and antioxidant properties: Insight into the development of novel radiosensitizing strategies. Mutation Res. 2017; 76-81.
  5. Hirashima H, Nakamura M, Miyabe Y, Mukumoto N, Uto M, Nakamura K, Mizowaki T, Hiraoka M. Geometric and dosimetric quality assurance using logfiles and a 3D helical diode detector for Dynamic WaveArc. Phys Med. 2017;43:107-13.
  6. Hirata K, Yoshimura M, Inoue M, Yamauchi C, Ogura M, Toi M, Suzuki E, Takeuchi M, Takada M, Hiraoka M. Regional recurrence in breast cancer patients with one to three positive axillary lymph nodes treated with breast-conserving surgery and whole breast irradiation. J Radiat Res. 2017;58:79-85.
  7. Hirata K, Yoshimura M, Mukumoto N, Nakamura M, Inoue M, Sasaki M, Fujimoto T, Yano S, Nakata M, Mizowaki T. Three-dimensional intrafractional internal target motions in accelerated partial breast irradiation using three-dimensional conformal external beam radiotherapy. Radioth Oncol. 2017;124:118-123.
  8. Hussein M CE, Eaton D, Greer P, Howarth A, Ishikura S, Kry S, Lehmann J, Lye J, Monti A, Nakamura M, Hurkmans C, Clark C. A virtual dosimetry audit – towards transferability of gamma index analysis between clinical trial QA groups. Radiother Oncol. 2017;125:398-404.
  9. Iizuka Y, Matsuo Y, Nakamura M, Kozawa S, Ueki N, Mitsuyoshi T, Mizowaki T, Hiraoka M. Optimization of a newly defined target volume in fiducial marker-based dynamic tumor-tracking radiotherapy. Imag. in Radiat. Oncol. 2017;4:1-5.
  10. Inokuchi H, Mizowaki T, Norihisa Y, Takayama K, Ikeda I, Nakamura K, Hiraoka M. Correlation between urinary dose and delayed radiation cystitis after 78 Gy intensity-modulated radiotherapy for high-risk prostate cancer: A 10-year follow-up study of genitourinary toxicity in clinical practice. Clin Transl Radiat Oncol. 2017;6:31-36.
  11. Ishihara Y, Nakamura M, Miyabe Y, Mukumoto N, Matsuo Y, Sawada A, Kokubo M, Mizowaki T, Hiraoka M. Development of a four-dimensional Monte Carlo dose calculation system for real-time tumor-tracking irradiation with a gimbaled X-ray head. Phys Med. 2017;35:59-65.
  12. Ito H, Itasaka S, Sakanaka K, Araki N, Mizowaki T, Hiraoka M. Long-term complications of definitive chemoradiotherapy for esophageal cancer using the classical method. J Radiat Res. 2017;58:106-113.
  13. Iwai A, Umeda K, Uto M, Nihira H, Kawaguchi K, Mikami M, Nodomi S, Saida S, Hiramatsu H, Ogura K, Tanji M, Arakawa Y, Sakamoto T, Adachi S, Mizowaki T, Heike T. Whole brain radiotherapy with volumetric-modulated arc therapy for pediatric intracranial embryonic carcinoma prevents permanent alopecia. Pediatr Blood Cancer. 2017;64.
  14. Jingu K, Matsuo Y, Onishi H, Yamamoto T, Aoki M, Murakami Y, Yamashita H, Kakuhara H, Nemoto K, Sakayauchi T, Okamoto M, Niibe Y, Nagata Y, Ogawa K. Dose Escalation Improves Outcome in Stereotactic Body Radiotherapy for Pulmonary Oligometastases from Colorectal Cancer. Anticancer Res. 2017;37:2709-2713.
  15. Kimura T, Nagata Y, Harada H, Hayashi S, Matsuo Y, Takanaka T, Kokubo M, Takayama K, Onishi H, Hirakawa K, Shioyama Y, Ehara T. Phase I study of stereotactic body radiation therapy for centrally located stage IA non-small cell lung cancer (JROSG10-1). Int J Clin Oncol. 2017;22:849-856.
  16. Mampuya WA, Matsuo Y, Nakamura A, Hiraoka M. Evaluation of the prevalence of burnout and psychological morbidity among radiation oncologist members of the Kyoto Radiation Oncology Study Group (KROSG). J Radiat Res. 2017;58:217-224.
  17. Hamaji M Chen-Yoshikawa TF, Matsuo Y, Motoyama H, Hijiya K, Menju T, Aoyama A, Sato T, Sonobe M, Date H. Salvage video-assisted thoracoscopic lobectomy for isolated local relapse after stereotactic body radiotherapy for early stage non-small cell lung cancer: technical aspects and perioperative management. J Vis Surg. 2017;3.
  18. Matsuo Y, Shibuya K, Okubo K, Ueki N, Aoyama A, Sonobe M, Nakamura M, Mizowaki T, Date T, Hiraoka M. Long-term outcomes of intensity-modulated radiotherapy following extra-pleural pneumonectomy for malignant pleural mesothelioma. Acta Oncologica. 2017;56:957-62.
  19. Mukumoto N, Nakamura M, Akimoto M, Miyabe Y, Yokota K, Matsuo Y, Mizowaki T, Hiraoka M. Impact of sampling interval in training data acquisition on intrafractional predictive accuracy of indirect dynamic tumor-tracking radiotherapy. Med Phys. 2017;44:3899-3908.
  20. Nakashima R, Goto Y, Koyasu S, Kobayashi M, Morinibu A, Yoshimura M, Hiraoka M, Hammond EM, Harada H. UCHL1-HIF-1 axis-mediated antioxidant property of cancer cells as a therapeutic target for radiosensitization. Sci Rep. 2017;31.
  21. Nodomi S, Umeda K, Ueno H, Saida S, Hiramatsu H, Funaki T, Arakawa Y, Mizowaki T, Adachi S, Heike T. Efficacy of Ifosfamide-Cisplatin-Etoposide (ICE) Chemotherapy for a CNS Germinoma in a Child With Down Syndrome. J Pediat Hematol Oncol. 2017;39:39-42.
  22. Onimaru R, Onishi H, Shibata T, Hiraoka M, Ishikura S, Karasawa K, Matsuo Y, Kokubo M, Shioyama Y, Matsushita H, Ito Y, Shirato H. Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer (JCOG0702): Results for the group with PTV100cc. Radiother Oncol. 2017;122:281-285.
  23. Ono T, Nakamura M, Hirose Y, Kitsuda K, Ono Y, Ishigaki T, Hiraoka M. Estimation of lung tumor position from multiple anatomical features on 4D-CT using multiple regression analysis. J Appl Clin Med Phys. 2017;18: 36-42.
  24. Sakanaka K, Itasaka S, Ishida Y, Fujii K, Horimatsu T, Mizowaki T, Sakai Y, Hiraoka M. Dosimetric advantages and clinical outcomes of simultaneous integrated boost intensity-modulated radiotherapy for anal squamous cell carcinoma. Radiat Oncol J. 2017;35:368-379.
  25. Shintani T, Matsuo Y, Iizuka Y, Mitsuyoshi T, Mizowaki T, Hiraoka M. Prognostic Significance of Serum CEA for Non-small Cell Lung Cancer Patients Receiving Stereotactic Body Radiotherapy. Anticancer Res. 2017;37:5161-5167.
  26. Shintani T, Matsuo Y, Iizuka Y, Mitsuyoshi T, Umeoka S, Nakamoto Y, Mizowaki T, Togashi K, Hiraoka M. Assessment of treatment response after lung stereotactic body radiotherapy using diffusion weighted magnetic resonance imaging and positron emission tomography: A pilot study. Eur J Radiol. 2017;92:58-63.
  27. Tsuruta Y, Nakamura M, Miyabe Y, Nakata M, Ishihara Y, Mukumoto N, Akimoto M, Ono T, Yano S, Higashimura K, Matsuo Y, Mizowaki T, Hiraoka M. Use of a second-dose calculation algorithm to check dosimetric parameters for the dose distribution of a first-dose calculation algorithm for lung SBRT plans. Phys Med. 2017;18:36-42.
  28. Uto M, Mizowaki T, Ogura K, Miyabe Y, Nakamura M, Mukumoto N, Hirashima H, Hiraoka M. Volumetric-modulated Dynamic WaveArc therapy reduces the dose to the hippocampus in patients with pituitary adenomas and craniopharyngiomas. Pract Radiat Oncol. 2017;7:382-387.
  29. Yamazaki H, Fushiki M, Mizowaki T, the Kansai Cancer Therapist Group. A surveillance study of the current status of reirradiation and patterns of practice. J Radiat Res. 2017;58:71-78.

 

2016
  1. Burghelea M, Verellen D, Poels K, Hung C, Nakamura M, Dhont J, Gevaert, T, Van den Begin R, Collen C, Matsuo Y, Kishi T, Simon V, Hiraoka, M. de Ridder M. Initial characterization, dosimetric benchmark and performance validation of Dynamic Wave Arc. Radiat Oncol 2016;11:63(pp1-10).
  2. Colvill E, Booth J, Nill S, Fast M, Bedford J, Oelfke U, Nakamura M, Poulsen P, Worm E, Hansen R, Ravkilde T, Scherman Rydhog J, Pommer T, Munck Af Rosenschold P, Lang S, Guckenberger M, Groh C, Herrmann C, Verellen D, Poels K, Wang L, Hadsell M, Sothmann T, Blanck O, Keall P. A dosimetric comparison of real-time adaptive and non-adaptive radiotherapy: A multi-institutional study encompassing robotic, gimbaled, multileaf collimator and couch tracking. Radiother Oncol 2016;119:159-65.
  3. Inokuchi H, Mizowaki T, Norihisa Y, Takayama K, Ikeda I, Nakamura K, Nakamura M, Hiraoka M. Clinical effect of multileaf collimator width on the incidence of late rectal bleeding after high-dose intensity-modulated radiotherapy for localized prostate carcinoma. Int J Clin Oncol 2016;21:156-61.
  4. Iramina H, Nakamura M, Iizuka Y, Mitsuyoshi T, Matsuo Y, Mizowaki T, Hiraoka M, Kanno I. The accuracy of extracted target motion trajectories in four-dimensional cone-beam computed tomography for lung cancer patients. Radiother Oncol 2016;121:46-51.
  5. Kishi T, Matsuo Y, Nakamura A, Nakamoto Y, Itasaka S, Mizowaki T, Togashi K, Hiraoka M. Comparative evaluation of respiratory-gated and ungated FDG-PET for target volume definition in radiotherapy treatment planning for pancreatic cancer. Radiother Oncol 2016;120:217-21.
  6. Kubota Y, Nakaigawa N. Committee for Establishment of the Clinical Practice Guideline for the Management of Bladder C, the Japanese Urological A. Essential content of evidence-based clinical practice guidelines for bladder cancer: The Japanese Urological Association 2015 update. Int J Urol 2016;23:640-5.
  7. Mampuya WA, Nakamura M, Hirose Y, Ishigaki T, Mizowaki T, Hiraoka M. Difference in dosevolumetric data between the analytical anisotropic algorithm, the dosetomedium, and the dosetowater reporting modes of the Acuros XB for lung stereotactic body radiation therapy. J Appl Clin Med Phys 2016;17:1-7.
  8. Matsuo Y, Nakamura M, Mizowaki T, Hiraoka M. Introduction of variance component analysis to setup error analysis in radiotherapy. Med Phys 2016;43:5195-8.
  9. Mitsuyoshi T, Nakamura M, Matsuo Y, Ueki N, Nakamura A, Iizuka Y, Mampuya WA, Mizowaki T, Hiraoka M. Dosimetric comparison of lung stereotactic body radiotherapy treatment plans using averaged computed tomography and end-exhalation computed tomography images: Evaluation of the effect of different dose-calculation algorithms and prescription methods. Med Dosim 2016;41:305-9.
  10. Mizowaki T, Norihisa Y, Takayama K, Ikeda I, Inokuchi H, Nakamura K, Kamba T, Inoue T, Kamoto T, Ogawa O, Hiraoka M. Ten-year outcomes of intensity-modulated radiation therapy combined with neoadjuvant hormonal therapy for intermediate- and high-risk patients with T1c-T2N0M0 prostate cancer. Int J Clin Oncol 2016;21:783-90.
  11. Mizowaki T, Norihisa Y, Takayama K, Ikeda I, Inokuchi H, Nakamura K, Kamba T, Inoue T, Kamoto T, Ogawa O, Hiraoka M. Long-term outcomes of intensity-modulated radiation therapy combined with neoadjuvant androgen deprivation therapy under an early salvage policy for patients with T3-T4N0M0 prostate cancer. Int J Clin Oncol 2016;21:148-55.
  12. Mukumoto N, Nakamura M, Takahashi K, Miyabe Y, Kaneko S, Mizowaki T, Kokubo M, Hiraoka. Development of a four-axis moving phantom for patient-specific QA of surrogate signal-based tracking IMRT. Med Phys 2016;43:6364-74.
  13. Nakamura M, Minemura T, Ishikura S, Nishio T, Narita Y, Nishimura Y. An on-site audit system for dosimetry credentialing of intensity-modulated radiotherapy in Japanese Clinical Oncology Group (JCOG) clinical trials. Phys Med 2016;32:987-91.
  14. Ono T, Miyabe Y, Yokota K, Takahashi K, Akimoto M, Mukumoto N, Ishihara Y, Nakamura M, Mizowaki T, Hiraoka M. Development of a gimbal-swing irradiation technique for uniform expanded-field, wedged-beam, and intensity-modulated radiation therapy. Biomed Phys Eng Express 2016;2:065007(pp1-13).
  15. Sakanaka K, Ishida Y, Itasaka S, Ezoe Y, Aoyama I, Miyamoto S, Horimatsu T, Muto M, Hiraoka M. Identification of a predictive factor for distant metastasis in esophageal squamous cell carcinoma after definitive chemoradiotherapy. Int J Clin Oncol 2016;21:899-908.
  16. Takamiya M, Nakamura M, Akimoto M, Ueki N, Yamada M, Tanabe H, Matsuo Y, Mizowaki T, Kokubo M, Hiraoka M. Multivariate analysis for the estimation of target localization errors in fiducial markerbased radiotherapy. Med Phys 2016;43:1907-12.
  17. Uto M, Mizowaki T, Ogura K, Arakawa Y, Mineharu Y, Miyamoto S, Hiraoka M. Feasibility evaluation of hypofractionated radiotherapy with concurrent temozolomide in elderly patients with glioblastoma. International journal of clinical oncology 2016;21:1023-9.
  18. Uto M, Mizowaki T, Ogura K, Hiraoka M. Non-coplanar volumetric-modulated arc therapy (VMAT) for craniopharyngiomas reduces radiation doses to the bilateral hippocampus: a planning study comparing dynamic conformal arc therapy, coplanar VMAT, and non-coplanar VMAT. Radiat Oncol 2016;11:86(pp1-8).
  19. Watanabe T, Hattori Y, Ohta Y, Ishimura M, Nakagawa Y, Sanada Y, Tanaka H, Fukutani S, Masunaga S, Hiraoka M. Comparison of the pharmacokinetics between L-BPA and L-FBPA using the same administration dose and protocol: a validation study for the theranostic approach using [18 F]-L-FBPA positron emission tomography in boron neutron capture therapy. BMC cancer 2016;16:859(pp1-10).
  20. Watanabe T, Tanaka H, Fukutani S, Suzuki M, Hiraoka M, Ono K. L-Phenylalanine preloading reduces the (10)B(n, alpha)(7)Li dose to the normal brain by inhibiting the uptake of boronophenylalanine in boron neutron capture therapy for brain tumours. Cancer Lett 2016;370:27-32.
2015
  1. Akimoto M, Nakamura M, Miyabe Y, Mukumoto N, Yamada M, Tanabe H, Ueki N, Kaneko S, Matsuo Y, Mizowaki T, Kokubo M, Hiraoka M. Baseline correction of a correlation model for improving the prediction accuracy of infrared marker-based dynamic tumor tracking. J Appl Clin Med Phys. 2015;16:14-22.
  2. Akimoto M, Nakamura M, Miyabe Y, Mukumoto N, Yokota K, Mizowaki T, Hiraoka M. Long-term stability assessment of a 4D tumor tracking system integrated into a gimbaled linear accelerator. J Appl Clin Med Phys 2015;16:373-80.
  3. Gaowa A, Horibe T, Kohno M, Tabata Y, Harada H, Hiraoka M, Kawakami K. Enhancement of anti-tumor activity of hybrid peptide in conjugation with carboxymethyl dextran via disulfide linkers. Eur J Pharm Biopharm 2015; 92:228-36.
  4. Goto Y, Zeng L, Yeom CJ, Zhu Y, Morinibu A, Shinomiya K, Kobayashi M, Hirota K, Itasaka S, Yoshimura M, Tanimoto K, Torii M, Sowa T, Menju T, Sonobe M,Kakeya H, Toi M, Date H, Hammond EM, Hiraoka M, Harada H. UCHL1 provides diagnostic and antimetastatic strategies due to its deubiquitinating effect on HIF-1alpha. Nature communications 2015;6:6153(pp1-13).
  5. Hirata K, Nakamura M, Yoshimura M, Mukumoto N, Nakata M, Ito H, Inokuchi H, Matsuo Y, Mizowaki T, Hiraoka M. Dosimetric evaluation of the Acuros XB algorithm for a 4 MV photon beam in head and neck intensity-modulated radiation therapy. J Appl Clin Med Phys. 2015;16:52-64.
  6. Iizuka Y, Matsuo Y, Ishihara Y, Akimoto M, Tanabe H, Takayama K, Ueki N, Yokota K, Mizowaki T, Kokubo M, Hiraoka M. Dynamic tumor-tracking radiotherapy with real-time monitoring for liver tumors using a gimbal mounted linac. Radiother Oncol 2015;117:496-500.
  7. Iizuka Y, Yoshimura M, Inokuchi H, Matsuo Y, Nakamura A, Mizowaki T, Hirano S, Kitamura M, Tateya I, Hiraoka M. Recurrence patterns after postoperative radiotherapy for squamous cell carcinoma of the pharynx and larynx. Acta Otolaryngol 2015;135:96-102.
  8. Ikeda I, Mizowaki T, Ono T, Yamada M, Nakamura M, Monzen H, Yano S, Hiraoka M. Effect of intrafractional prostate motion on simultaneous boost intensity-modulated radiotherapy to the prostate: a simulation study based on intrafractional motion in the prone position. Med Dosim 2015;40:325-32.
  9. Inoue M, Yoshimura M, Sato S, Nakamura M, Yamada M, Hirata K, Sasaki M, Fujimoto T, Ogura M, Hiraoka M. Improvement of registration accuracy in accelerated partial breast irradiation using the point-based rigid-body registration algorithm for patients with implanted fiducial markers. Med Phys 2015;42:1904-10.
  10. Kishi T, Matsuo Y, Ueki N, Iizuka Y, Nakamura A, Sakanaka K, Mizowaki T, Hiraoka M. Pretreatment modified Glasgow Prognostic Score predicts clinical outcomes after stereotactic body radiotherapy for early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2015;92:620-7.
  11. Matsuo Y, Verellen D, Poels K, Mukumoto N, Depuydt T, Akimoto M, Nakamura M, Ueki N, Engels B, Collen C, Kokubo M, Hiraoka M, De ridder M. A multi-centre analysis of treatment procedures and error components in dynamic tumour tracking radiotherapy. Radiother Oncol 2015:115:412-8.
  12. Mizowaki T, Aoki M, Nakamura K, Yorozu A, Kokubo M, Karasawa K, Kozuka T, Nakajima N, Sasai K, Akimoto T. Current status and outcomes of patients developing PSA recurrence after prostatectomy who were treated with salvage radiotherapy: a JROSG surveillance study. J Radiat Res 2015;56:750-6.
  13. Monzen H, Mizowaki T, Yano S, Fujimoto T, Kamomae T, Utsunomiya S, Nakamura M, Hiraoka M. Impact of the Vero4DRT (MHI-TM2000) on the Total Treatment Time in Stereotactic Irradiation. J Nucl Med Radiat Ther 2015;06:1000238(pp1-4).
  14. Monzen H, Chen F, Matsuo Y, Kawaguchi A, Morita S, Ueki N, Sonobe M, Nagata Y, Hiraoka M, Date H. Video-assisted thoracoscopic lobectomy versus stereotactic radiotherapy for stage I lung cancer. Ann Thorac Surg 2015;99:1122-9.
  15. Nakamura M, Akimoto M, Mukumoto N, Yamada M, Tanabe H, Ueki N, Matsuo Y, Mizowaki T, Kokubo M, Hiraoka M. Influence of the correlation modeling period on the prediction accuracy of infrared marker-based dynamic tumor tracking using a gimbaled X-ray head. Phys Med 2015;31:204-9.
  16. Nakamura M, Takamiya M, Akimoto M, Ueki N, Yamada M, Tanabe H, Mukumoto N, Yokota K, Matsuo Y, Mizowaki T, Kokubo M, Hiraoka M. Target localization errors from fiducial markers implanted around a lung tumor for dynamic tumor tracking. Phys Med 2015;31:934-41.
  17. Nakamura M, Akimoto M, Ono T, Nakamura A, Yano S, Nakata M, Itasaka S, Mizowaki T, Shibuya K, Hiraoka M. Interfraction Positional Variation in Pancreatic Tumors using Daily Breath-hold Cone-beam Computed Tomography with Visual Feedback. J Appl Clin Med Phys. 2015;16:108-16.
  18. Nakayama S, Monzen H, Oonishi Y, Mizote R, Iramina H, Kaneshige S, Mizowaki T. A novel method for dose distribution registration using fiducial marks made by a megavoltage beam in film dosimetry for intensity-modulated radiation therapy quality assurance. Phys Med 2015;31:414-9.
  19. Onimaru R, Shirato H, Shibata T, Hiraoka M, Ishikura S, Karasawa K, Matsuo Y, Kokubo M, Shioyama Y, Matsushita H, Ito Y, Onishi H. Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer with PTV<100 cc using a continual reassessment method (JCOG0702). Radiother Oncol 2015;116:276-80.
  20. Sato S, Miyabe Y, Takahashi K, Yamada M, Nakamura M, Ishihara Y, Yokota K, Kaneko S, Mizowaki T, Monzen H, Hiraoka M. Commissioning and quality assurance of Dynamic WaveArc irradiation. J Appl Clin Med Phys 2015;16:73-86.
  21. Shintani T, Masago K, Takayama K, Ueki K, Kimino G, Ueki N, Kosaka Y, Imagumbai T, Katakami N, Kokubo M. Stereotactic Body Radiotherapy for Synchronous Primary Lung Cancer: Clinical Outcome of 18 Cases. Clin Lung Cancer 2015;16:e91-6.
  22. Ueki N, Matsuo Y, Togashi Y, Kubo T, Shibuya K, Iizuka Y, Mizowaki T, Togashi K, Mishima M, Hiraoka M. Impact of pretreatment interstitial lung disease on radiation pneumonitis and survival after stereotactic body radiation therapy for lung cancer. J Thorac Oncol 2015;10:116-25.
  23. Umeda K, Shibata H, Saida S, Hiramatsu H, Arakawa Y, Mizowaki T, Nishiuchi R, Adachi S, Heike T, Watanabe K. Long-term efficacy of bevacizumab and irinotecan in recurrent pediatric glioblastoma. Pediatr Int 2015;57:169-71.
  24. Yamashita H, Onishi H, Murakami N, Matsumoto Y, Matsuo Y, Nomiya T, Nakagawa K. Survival outcomes after stereotactic body radiotherapy for 79 Japanese patients with hepatocellular carcinoma. J Radiat Res 2015;56:561-7.
2014
  1. Aoki M, Mizowaki T, Akimoto T, Nakamura K, Ejima Y, Jingu K, Tamai Y, Nakajima N, Takemoto S, Kokubo M and Katoh H. Adjuvant radiotherapy after prostatectomy for prostate cancer in Japan: a multi-institutional survey study of the JROSG. J Radiat Res 2014;55:533-540.
  2. Gaowa A, Horibe T, Kohno M, Sato K, Harada H, Hiraoka M, Tabata Y and Kawakami K. Combination of hybrid peptide with biodegradable gelatin hydrogel for controlled release and enhancement of anti-tumor activity in vivo. Journal of controlled release : official journal of the Controlled Release Society 2014;176:1-7.
  3. Iizuka Y, Matsuo Y, Umeoka S, Nakamoto Y, Ueki N, Mizowaki T, Togashi K and Hiraoka M. Prediction of clinical outcome after stereotactic body radiotherapy for non-small cell lung cancer using diffusion-weighted MRI and (18)F-FDG PET. European journal of radiology 2014;83:2087-2092.
  4. Ikeda I, Mizowaki T, Norihisa Y, Takayama K, Kamba T, Inoue T, Nakamura E, Kamoto T, Ogawa O and Hiraoka M. Long-term outcomes of dynamic conformal arc irradiation combined with neoadjuvant hormonal therapy in Japanese patients with T1c-T2N0M0 prostate cancer: case series study. Jpn J Clin Oncol 2014;44:180-185.
  5. Ikeda I, Mizowaki T, Sawada Y, Nakata M, Norihisa Y, Ogura M and Hiraoka M. Assessment of interfractional prostate motion in patients immobilized in the prone position using a thermoplastic shell. J Radiat Res 2014;55:168-174.
  6. Koubuchi S, Takakura T, Nakamura M, Mizowaki T, Nakata M and Hiraoka M. Accuracy of positional correction for the floor-mounted kV X-ray IGRT system in angled couch positions. Radiol Phys Technol 2014;7:373-378.
  7. Mampuya W A, Matsuo Y, Ueki N, Nakamura M, Mukumoto N, Nakamura A, Iizuka Y, Kishi T, Mizowaki T and Hiraoka M. The impact of abdominal compression on outcome in patients treated with stereotactic body radiotherapy for primary lung cancer. J Radiat Res 2014;55:934-939.
  8. Matsuo Y, Chen F, Hamaji M, Kawaguchi A, Ueki N, Nagata Y, Sonobe M, Morita S, Date H and Hiraoka M. Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage I non-small-cell lung cancer in patients at high risk for lobectomy: A propensity score matching analysis. European journal of cancer 2014:in press.
  9. Matsuo Y, Ueki N, Takayama K, Nakamura M, Miyabe Y, Ishihara Y, Mukumoto N, Yano S, Tanabe H, Kaneko S, Mizowaki T, Monzen H, Sawada A, Kokubo M and Hiraoka M. Evaluation of dynamic tumour tracking radiotherapy with real-time monitoring for lung tumours using a gimbal mounted linac. Radiother Oncol 2014:in press.
  10. Miki K, Hashimoto H, Inoue T, Matsuoka H, Harada H, Hiraoka M and Ohe K. Sonication-induced formation of size-controlled self-assemblies of amphiphilic Janus-type polymers as optical tumor-imaging agents. Small 2014;10:3119-3130.
  11. Mukumoto N, Nakamura M, Yamada M, Takahashi K, Tanabe H, Yano S, Miyabe Y, Ueki N, Kaneko S, Matsuo Y, Mizowaki T, Sawada A, Kokubo M and Hiraoka M. Intrafractional tracking accuracy in infrared marker-based hybrid dynamic tumour-tracking irradiation with a gimballed linac. Radiother Oncol 2014;111:301-305.
  12. Nakamura A, Itasaka S, Takaori K, Kawaguchi Y, Shibuya K, Yoshimura M, Matsuo Y, Mizowaki T, Uemoto S and M. H. Radiotherapy for patients with isolated local recurrence of primary resected pancreatic cancer : Prolonged disease-free interval associated with favorable prognosis. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft … [et al] 2014;190:485-490.
  13. Ogura K, Mizowaki T, Ishida Y and Hiraoka M. Dosimetric advantages of O-ring design radiotherapy system for skull-base tumors. J Appl Clin Med Phys 2014;15:4608.
  14. Sakanaka K, Matsuo Y, Nagata Y, Maki S, Shibuya K, Norihisa Y, Narabayashi M, Ueki N, Mizowaki T and Hiraoka M. Safety and effectiveness of stereotactic body radiotherapy for a clinically diagnosed primary stage I lung cancer without pathological confirmation. Int J Clin Oncol 2014;19:814-821.
  15. Satoshi Koubuchi T T, Mitsuhiro Nakamura, Takashi Mizowaki, Manabu Nakata, Masahiro Hiraoka. Accuracy of positional correction for the floor-mounted kV X-ray IGRT system in angled couch positions. Radiol Phys Technol 2014;7:373-378.
  16. Shiinoki T, Sawada A, Ishihara Y, Miyabe Y, Matsuo Y, Mizowaki T, Kokubo M and Hiraoka M. Dosimetric impact of gold markers implanted closely to lung tumors: a Monte Carlo simulation. J Appl Clin Med Phys 2014;15:4594.
  17. Watanabe T, Mizowaki T, Arakawa Y, Iizuka Y, Ogura K, Sakanaka K, Miyamoto S and Hiraoka M Pineal parenchymal tumor of intermediate differentiation: Treatment outcomes of five cases. Molecular and Clinical Oncology 2014;2:197-202.
  18. Tomohiro Ono Y M, Masahiro Yamada, Takehiro Shiinoki, Akira Sawada, Shuji Kaneko, Hajime Monzen, Takashi Mizowaki, Masaki Kokubo, Masahiro Hiraoka. Geometric and dosimetric accuracy of dynamic tumor-tracking conformal arc irradiation with a gimbaled x-ray head. Medical physics 2014;41:pp1-8.
  19. Tomohiro Ono Y M, Masahiro Yamada, Kenji Yokota, Shuji Kaneko, Akira Sawada, Hajime Monzen, Takashi Mizowaki, Masaki Kokubo, Masahiro Hiraoka. Development of an expanded-field irradiation technique using a gimbaled x-ray head. Medical physics 2014;41:101706(pp101711).
  20. Tsuruta Y, Nakata M, Nakamura M, Matsuo Y, Higashimura K, Monzen H, Mizowaki T and Hiraoka M. Dosimetric comparison of Acuros XB, AAA, and XVMC in stereotactic body radiotherapy for lung cancer. Med Phys 2014;41:081715.
  21. Ueki N, Matsuo Y, Nakamura M, Mukumoto N, Iizuka Y, Miyabe Y, Sawada A, Mizowaki T, Kokubo M and Hiraoka M. Intra- and interfractional variations in geometric arrangement between lung tumours and implanted markers. Radiother Oncol 2014;110:523-528.
  22. Watanabe T, Mizowaki T, Arakawa Y, Iizuka Y, Ogura K, Sakanaka K, Miyamoto S and Hiraoka M. Pineal parenchymal tumor of intermediate differentiation: Treatment outcomes of five cases. Mol Clin Oncol 2014;2:197-202.
  23. Yamashita H, Onishi H, Matsumoto Y, Murakami N, Matsuo Y, Nomiya T, Nakagawa K and Japanese Radiological Society multi-institutional S s g. Local effect of stereotactic body radiotherapy for primary and metastatic liver tumors in 130 Japanese patients. Radiation oncology 2014;9:112.
  24. Yoshioka Y, Ogawa K, Oikawa H, Onishi H, Uchida N, Maebayashi T, Kanesaka N, Tamamoto T, Asakura H, Kosugi T, Hatano K, Yoshimura M, Yamada K, Tokumaru S, Sekiguchi K, Kobayashi M, Soejima T, Isohashi F, Nemoto K, Nishimura Y and Japanese Radiation Oncology Study G. Factors influencing survival outcome for radiotherapy for biliary tract cancer: A multicenter retrospective study. Radiother Oncol 2014.
  25. Zeng L, Morinibu A, Kobayashi M, Zhu Y, Wang X, Goto Y, Yeom C J, Zhao T, Hirota K, Shinomiya K, Itasaka S, Yoshimura M, Guo G, Hammond E M, Hiraoka M and Harada H. Aberrant IDH3alpha expression promotes malignant tumor growth by inducing HIF-1-mediated metabolic reprogramming and angiogenesis. Oncogene 2014.
  26. Zhao T, Zhu Y, Morinibu A, Kobayashi M, Shinomiya K, Itasaka S, Yoshimura M, Guo G, Hiraoka M and Harada H. HIF-1-mediated metabolic reprogramming reduces ROS levels and facilitates the metastatic colonization of cancers in lungs. Scientific reports 2014;4:3793.
2013
  1. Akimoto M, Nakamura M, Mukumoto N, Tanabe H, Yamada M, Matsuo Y, Monzen H, Mizowaki T, Kokubo M and Hiraoka M. Predictive uncertainty in infrared marker-based dynamic tumor tracking with Vero4DRT. Med Phys 2013;40:091705.
  2. Eriguchi T, Takeda A, Oku Y, Ishikura S, Kimura T, Ozawa S, Nakashima T, Matsuo Y, Nakamura M, Matsumoto Y, Yamazaki S, Sanuki N and Ito Y. Multi-institutional comparison of treatment planning using stereotactic ablative body radiotherapy for hepatocellular carcinoma — benchmark for a prospective multi-institutional study. Radiation oncology 2013;8:113.
  3. Fujita M, Sasanuma H, Yamamoto K N, Harada H, Kurosawa A, Adachi N, Omura M, Hiraoka M, Takeda S and Hirota K. Interference in DNA replication can cause mitotic chromosomal breakage unassociated with double-strand breaks. PLoS One 2013;8:e60043.
  4. Ikeda I, Mizowaki T, Norihisa Y, Takayama K, Kamba T, Inoue T, Nakamura E, Kamoto T, Ogawa O and Hiraoka M. Long-term Outcomes of Dynamic Conformal Arc Irradiation Combined with Neoadjuvant Hormonal Therapy in Japanese Patients with T1c-T2N0M0 Prostate Cancer: Case Series Study. Jpn J Clin Oncol 2013.
  5. Isobe T, Onn A, Morgensztern D, Jacoby J J, Wu W, Shintani T, Itasaka S, Shibuya K, Koo P J, O’Reilly M S and Herbst R S. Evaluation of novel orthotopic nude mouse models for human small-cell lung cancer. J Thorac Oncol 2013;8:140-146.
  6. Ikeda I, Mizowaki T, Sawada Y, Nakata M, Norihisa Y, Ogura M and Hiraoka M. Assessment of interfractional prostate motion in patients immobilized in the prone position using a thermoplastic shell. Journal of Radiation Research 2013.
  7. Iwata H, Masuda N, Ohno S, Rai Y, Sato Y, Ohsumi S, Hashigaki S, Nishizawa Y, Hiraoka M, Morimoto T, Sasano H, Saeki T and Noguchi S. A randomized, double-blind, controlled study of exemestane versus anastrozole for the first-line treatment of postmenopausal Japanese women with hormone-receptor-positive advanced breast cancer. Breast cancer research and treatment 2013.
  8. Mami Akimoto M N, Nobutaka Mukumoto, Hiroaki Tanabe, Masahiro Yamada, Yukinori Matsuo, Hajime Monzen, Takashi Mizowaki, Masaki Kokubo, and Masahiro Hiraoka. Predictive uncertainty in infrared marker-based dynamic tumor tracking with Vero4DRT. Medical physics 2013;40:8.
  9. Mampuya W A, Matsuo Y, Nakamura A, Nakamura M, Mukumoto N, Miyabe Y, Narabayashi M, Sakanaka K, Mizowaki T and Hiraoka M. Differences in dose-volumetric data between the analytical anisotropic algorithm and the x-ray voxel Monte Carlo algorithm in stereotactic body radiation therapy for lung cancer. Med Dosim 2013;38:95-99.
  10. Mampuya W A, Nakamura M, Matsuo Y, Ueki N, Iizuka Y, Fujimoto T, Yano S, Monzen H, Mizowaki T and Hiraoka M. Interfraction variation in lung tumor position with abdominal compression during stereotactic body radiotherapy. Med Phys 2013;40:091718.
  11. Matsugi K, Nakamura M, Miyabe Y, Yamauchi C, Matsuo Y, Mizowaki T and Hiraoka M. Evaluation of 4D dose to a moving target with Monte Carlo dose calculation in stereotactic body radiotherapy for lung cancer. Radiol Phys Technol 2013;6:233-240.
  12. Matsuo Y, Onishi H, Nakagawa K, Nakamura M, Ariji T, Kumazaki Y, Shimbo M, Tohyama N, Nishio T, Okumura M, Shirato H and Hiraoka M. Guidelines for respiratory motion management in radiation therapy. J Radiat Res 2013;54:561-568.
  13. Mitsuhiro Nakamura A S, Nobutaka Mukumoto, Kunio Takahashi, Takashi Mizowaki, Masaki Kokubo, Masahiro Hiraoka. Effect of audio instruction on tracking errors using a four-dimensional image-guided radiotherapy system. Journal of applied clinical medical physics / American College of Medical Physics 2013;14:10.
  14. Mizowaki T, Takayama K, Nagano K, Miyabe Y, Matsuo Y, Kaneko S, Kokubo M and Hiraoka M. Feasibility evaluation of a new irradiation technique: three-dimensional unicursal irradiation with the Vero4DRT (MHI-TM2000). Journal of radiation research 2013;54:330-336.
  15. Mukumoto N, Nakamura M, Sawada A, Suzuki Y, Takahashi K, Miyabe Y, Kaneko S, Mizowaki T, Kokubo M and Hiraoka M. Accuracy verification of infrared marker-based dynamic tumor-tracking irradiation using the gimbaled x-ray head of the Vero4DRT (MHI-TM2000). Med Phys 2013;40:041706-041701-041709.
  16. Nakamura A, Shibuya K, Nakamura M, Matsuo Y, Shiinoki T, Nakata M, Mizowaki T and Hiraoka M. Interfractional dose variations in the stomach and the bowels during breathhold intensity-modulated radiotherapy for pancreatic cancer: Implications for a dose-escalation strategy. Med Phys 2013;40:021701.
  17. Ogura K, Mizowaki T, Arakawa Y, Ogura M, Sakanaka K, Miyamoto S and Hiraoka M. Initial and cumulative recurrence patterns of glioblastoma after temozolomide-based chemoradiotherapy and salvage treatment: a retrospective cohort study in a single institution. Radiation oncology 2013;8:97.
  18. Ogura K, Mizowaki T, Arakawa Y, Sakanaka K, Miyamoto S and Hiraoka M. Efficacy of salvage stereotactic radiotherapy for recurrent glioma: impact of tumor morphology and method of target delineation on local control. Cancer medicine 2013;2:942-949.
  19. Takakura T, Nakamura M, Shibuya K, Nakata M, Nakamura A, Matsuo Y, Shiinoki T, Higashimura K, Teshima T and Hiraoka M. Effects of interportal error on dose distribution in patients undergoing breath-holding intensity-modulated radiotherapy for pancreatic cancer: evaluation of a new treatment planning method. J Appl Clin Med Phys 2013;14:4252.
  20. Ueki N, Matsuo Y, Shibuya K, Nakamura M, Narabayashi M, Sakanaka K, Norihisa Y, Mizowaki T and Hiraoka M. Differences in the dose-volume metrics with heterogeneity correction status and its influence on local control in stereotactic body radiation therapy for lung cancer. J Radiat Res 2013;54:337-343.
  21. Utsunomiya S M H, Mukumoto N, Akimoto M, Mukumoto N, Ishihara Y, Shiinoki T, Nakamra M, Miyabe Y, Sato S, Matsuo S, Hiraoka M. A feasibility study on reduction of the entrance-surface dose to neonates by use of a new digital mobile X-ray system. Radiological physics and technology 2013;6:157-161.
  22. Mampuya W A, Matsuo Y, Ueki N, Iizuka Y, Fujimoto T, Yano S, Monzen H, Mizowaki T, and Hiraoka M. Interfraction variation in lung tumor position with abdominal compression during stereotactic body radiotherapy. Medical physics 2013;40:7.
  23. Watanabe T, Monzen H, Hara M, Mizowaki T and Hiraoka M. Pharmacokinetic model of myocardial (99m)Tc-sestamibi washout. Ann Nucl Med 2013;27:279-284.
  24. Zhu Y, Zhao T, Itasaka S, Zeng L, Yeom C J, Hirota K, Suzuki K, Morinibu A, Shinomiya K, Ou G, Yoshimura M, Hiraoka M and Harada H. Involvement of decreased hypoxia-inducible factor 1 activity and resultant G1-S cell cycle transition in radioresistance of perinecrotic tumor cells. Oncogene 2013;32:2058-2068.
2012
  1. Akimoto M, Nakamura M, Mukumoto N, Yamada M, Ueki N, Matsuo Y, Sawada A, Mizowaki T, Kokubo M Hiraoka M. Optimization of the x-ray monitoring angle for creating a correlation model between internal and external respiratory signals. Med Phys 2012;39:6309-6315.
  2. Chen F, Okubo K, Sonobe M, Shibuya K, Matsuo Y, Kim YH, Yanagihara K, Bando T Date H. Hyperfractionated irradiation with 3 cycles of induction chemotherapy in stage iiia-n2 lung cancer. World journal of surgery 2012;36:2858-2864.
  3. Harada H, Inoue M, Itasaka S, Hirota K, Morinibu A, Shinomiya K, Zeng L, Ou G, Zhu Y, Yoshimura M, McKenna WG, Muschel RJ Hiraoka M. Cancer cells that survive radiation therapy acquire hif-1 activity and translocate towards tumour blood vessels. Nature communications 2012;3:783.
  4. Kai S, Tanaka T, Daijo H, Harada H, Kishimoto S, Suzuki K, Takabuchi S, Takenaga K, Fukuda K Hirota K. Hydrogen sulfide inhibits hypoxia- but not anoxia-induced hypoxia-inducible factor 1 activation in a von hippel-lindau- and mitochondria-dependent manner. Antioxid Redox Signal 2012;16:203-216.
  5. Li Z, Kawamura K, Kawashita M, Kudo TA, Kanetaka H Hiraoka M. In vitro assessment of poly(methylmethacrylate)-based bone cement containing magnetite nanoparticles for hyperthermia treatment of bone tumor. J Biomed Mater Res A 2012;100:2537-2545.
  6. Matsuo Y, Shibuya K, Nagata Y, Norihisa Y, Narabayashi M, Sakanaka K, Ueki N, Mizowaki T Hiraoka M. Preliminary report of late recurrences, at 5 years or more, after stereotactic body radiation therapy for non-small cell lung cancer. J Thorac Oncol 2012;7:453-456.
  7. Matsuo Y, Shibuya K, Nakamura M, Narabayashi M, Sakanaka K, Ueki N, Miyagi K, Norihisa Y, Mizowaki T, Nagata Y Hiraoka M. Dose–volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer. Int J Radiat Oncol Biol Phys 2012;83:e545-549.
  8. Miki K NK, Matsuoka H, Yeom CJ, Harada H, Hiraoka M, Ohe K. Amphiphilic brush-like copolymers involving hydrophobic amino acid- and oligopeptide-side chains for optical tumor imaging in vivo. Bull Chem Soc. 2012;85:1277-1286.
  9. Mizowaki T, Hatano K Hiraoka M. Surveillance on interfacility differences in dose-prescription policy of intensity-modulated radiation therapy plans for prostate cancer. Journal of radiation research 2012;53:608-614.
  10. Mizowaki T, Takayama K, Norihisa Y, Ogura M, Kamba T, Inoue T, Shimizu Y, Kamoto T, Ogawa O Hiraoka M. Long-term outcomes of three-dimensional conformal radiation therapy combined with neoadjuvant hormonal therapy for japanese patients with t1c-t2n0m0 prostate cancer. International journal of clinical oncology 2012;17:562-568.
  11. Mukumoto N, Nakamura M, Sawada A, Takahashi K, Miyabe Y, Takayama K, Mizowaki T, Kokubo M Hiraoka M. Positional accuracy of novel x-ray-image-based dynamic tumor-tracking irradiation using a gimbaled mv x-ray head of a vero4drt (mhi-tm2000). Med Phys 2012;39:6287-6296.
  12. Nakamura A, Shibuya K, Matsuo Y, Nakamura M, Shiinoki T, Mizowaki T Hiraoka M. Analysis of dosimetric parameters associated with acute gastrointestinal toxicity and upper gastrointestinal bleeding in locally advanced pancreatic cancer patients treated with gemcitabine-based concurrent chemoradiotherapy. Int J Radiat Oncol Biol Phys 2012;84:369-375.
  13. Nakamura K, Akimoto T, Mizowaki T, Hatano K, Kodaira T, Nakamura N, Kozuka T, Shikama N Kagami Y. Patterns of practice in intensity-modulated radiation therapy and image-guided radiation therapy for prostate cancer in japan. Japanese journal of clinical oncology 2012;42:53-57.
  14. Nakamura M, Kishimoto S, Iwamura K, Shiinoki T, Nakamura A, Matsuo Y, Shibuya K Hiraoka M. Dosimetric investigation of breath-hold intensity-modulated radiotherapy for pancreatic cancer. Med Phys 2012;39:48-54.
  15. Nakamura M, Miyabe Y, Matsuo Y, Kamomae T, Nakata M, Yano S, Sawada A, Mizowaki T Hiraoka M. Experimental validation of heterogeneity-corrected dose-volume prescription on respiratory-averaged ct images in stereotactic body radiotherapy for moving tumors. Med Dosim 2012;37:20-25.
  16. Nakamura M, Shibuya K, Nakamura A, Shiinoki T, Matsuo Y, Nakata M, Sawada A, Mizowaki T Hiraoka M. Interfractional dose variations in intensity-modulated radiotherapy with breath-hold for pancreatic cancer. Int J Radiat Oncol Biol Phys 2012;82:1619-1626.
  17. Narabayashi M, Mizowaki T, Matsuo Y, Nakamura M, Takayama K, Norihisa Y, Sakanaka K Hiraoka M. Dosimetric evaluation of the impacts of different heterogeneity correction algorithms on target doses in stereotactic body radiation therapy for lung tumors. J Radiat Res 2012;53:777-784.
  18. Nishimura Y, Koike R, Ogawa K, Sasamoto R, Murakami Y, Itoh Y, Negoro Y, Itasaka S, Sakayauchi T Tamamoto T. Clinical practice and outcome of radiotherapy for esophageal cancer between 1999 and 2003: The japanese radiation oncology study group (jrosg) survey. Int J Clin Oncol 2012;17:48-54.
  19. Norihisa Y, Mizowaki T, Takayama K, Miyabe Y, Matsugi K, Matsuo Y, Narabayashi M, Sakanaka K, Nakamura A, Nagata Y Hiraoka M. Detailed dosimetric evaluation of intensity-modulated radiation therapy plans created for stage c prostate cancer based on a planning protocol. Int J Clin Oncol 2012;17:505-511.
  20. Nozaki M, Kagami Y, Mitsumori M Hiraoka M. A multicenter investigation of late adverse events in japanese women treated with breast-conserving surgery plus conventional fractionated whole-breast radiation therapy. Jpn J Clin Oncol 2012.
  21. Ogura K, Mizowaki T, Ogura M, Sakanaka K, Arakawa Y, Miyamoto S Hiraoka M. Outcomes of hypofractionated stereotactic radiotherapy for metastatic brain tumors with high risk factors. J Neurooncol 2012;109:425-432.
  22. Saji S, Hiraoka M, Tokuda Y, Fukui N Ikeda T. Trends in local therapy application for early breast cancer patients in the japanese breast cancer society breast cancer registry during 2004-2009. Breast Cancer 2012;19:1-3.
  23. Sakanaka K, Mizowaki T Hiraoka M. Dosimetric advantage of intensity-modulated radiotherapy for whole ventricles in the treatment of localized intracranial germinoma. Int J Radiat Oncol Biol Phys 2012;82:e273-280.
  24. Yeom CJ, Goto Y, Zhu Y, Hiraoka M Harada H. Microenvironments and cellular characteristics in the micro tumor cords of malignant solid tumors. International journal of molecular sciences 2012;13:13949-13965.
  25. Youshi Fujita, Takahiro Kuchimaru, Tetsuya Kadonosono, Shotaro Tanaka, Yoshiki Hase, Hidekazu Tomimoto, Masahiro Hiraoka, Shinae Kizaka-Kondoh, Masafumi Ihara Takahashi R. In vivo imaging of brain ischemia using an oxygen-dependent degradative fusion protein probe. PLOS ONE 2012.
2011
  1. Higashi T, Nishii R, Yamada S, Nakamoto Y, Ishizu K, Kawase S, Togashi K, Itasaka S, Hiraoka M, Misaki T, Konishi J: Delayed initial radioactive iodine therapy resulted in poor survival in patients with metastatic differentiated thyroid carcinoma: a retrospective statistical analysis of 198 cases. J Nucl Med2011, 52(5):683-689. PMID:21498534
  2. Hiraoka M:[Current situation and perspectives of radiation oncology].Nihon Rinsho2011, 69 Suppl 5:404-407. PMID:22208011
  3. Ishikura S, Ito Y, Hiraoka M: JCOG Radiation Therapy Study Group: History and Achievements. Jpn J Clin Oncol 2011. PMID:21980050
  4. Li Z, Kawashita M, Araki N, Mitsumori M, Hiraoka M, Doi M:Preparation of magnetic iron oxide nanoparticles for hyperthermia of cancer in a FeCl?-NaNO?-NaOH aqueous system. J Biomater Appl 2011, 25(7):643-661. PMID:20207773
  5. Matsuo Y, Shibuya K, Nagata Y, Norihisa Y, Narabayashi M, Sakanaka K, Ueki N, Mizowaki T, Hiraoka M: Preliminary report of late recurrences, at 5 years or more, after stereotactic body radiation therapy for non-small cell lung cancer. J Thorac Oncol2012, 7(2):453-456. PMID:22252562
  6. Matsuo Y, Shibuya K, Nagata Y, Takayama K, Norihisa Y, Mizowaki T, Narabayashi M, Sakanaka K, Hiraoka M: Prognostic factors in stereotactic body radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2011, 79(4):1104-1111. PMID:20472343
  7. Miki K, Kimura A, Oride K, Kuramochi Y, Matsuoka H, Harada H, Hiraoka M, Ohe K: High-Contrast Fluorescence Imaging of Tumors In Vivo Using Nanoparticles of Amphiphilic Brush-Like Copolymers Produced by ROMP.Angew Chem Int Ed Engl 2011. PMID:21656616
  8. Miyabe Y, Sawada A, Takayama K, Kaneko S, Mizowaki T, Kokubo M, Hiraoka M: Positioning accuracy of a new image-guided radiotherapy system. Med Phys 2011, 38(5):2535-2541. PMID:21776788
  9. Mizowaki T, Takayama K, Norihisa Y, Ogura M, Kamba T, Inoue T, Shimizu Y, Kamoto T, Ogawa O, Hiraoka M: Long-term outcomes of three-dimensional conformal radiation therapy combined with neoadjuvant hormonal therapy for Japanese patients with T1c-T2N0M0 prostate cancer.Int J Clin Oncol2011. PMID:21968911
  10. Nakajima A, Nishiyama K, Morimoto M, Nakamura S, Suzuki O, Kawaguchi Y, Miyagi K, Fujii T, Yoshino K:Definitive Radiotherapy for T1-2 Hypopharyngeal Cancer: A Single-Institution Experience.Int J Radiat Oncol Biol Phys 2011. PMID:21640496
  11. Nakamura M, Kishimoto S, Iwamura K, Shiinoki T, Nakamura A, Matsuo Y, Shibuya K, Hiraoka M:Dosimetric investigation of breath-hold intensity-modulated radiotherapy for pancreatic cancer. Med Phys 2012, 39(1):48. PMID:22225274
  12. Nakamura M, Miyabe Y, Matsuo Y, Kamomae T, Nakata M, Yano S, Sawada A, Mizowaki T, Hiraoka M: Experimental validation of heterogeneity-corrected dose-volume prescription on respiratory-averaged CT images in stereotactic body radiotherapy for moving tumors.Med Dosim2011. PMID:21497502
  13. Nakamura M, Shibuya K, Nakamura A, Shiinoki T, Matsuo Y, Nakata M, Sawada A, Mizowaki T, Hiraoka M: Interfractional Dose Variations in Intensity-Modulated Radiotherapy With Breath-Hold for Pancreatic Cancer.Int J Radiat Oncol Biol Phys2011. PMID:21477941
  14. Nakamura M, Shibuya K, Shiinoki T, Matsuo Y, Nakamura A, Nakata M, Sawada A, Mizowaki T, Hiraoka M: Positional reproducibility of pancreatic tumors under end-exhalation breath-hold conditions using a visual feedback technique. Int J Radiat Oncol Biol Phys 2011, 79(5):1565-1571. PMID:20832187
  15. Norihisa Y, Mizowaki T, Takayama K, Miyabe Y, Matsugi K, Matsuo Y, Narabayashi M, Sakanaka K, Nakamura A, Nagata Y, Hiraoka M: Detailed dosimetric evaluation of intensity-modulated radiation therapy plans created for stage C prostate cancer based on a planning protocol.Int J Clin Oncol2011. PMID:21960356
  16. Numasaki H, Shibuya H, Nishio M, Ikeda H, Sekiguchi K, Kamikonya N, Koizumi M, Tago M, Ando Y, Tsukamoto N, Terahara A, Nakamura K, Mitsumori M, Nishimura T, Hareyama M, Teshima T, Committee JSoTRaOD: National Medical Care System May Impede Fostering of True Specialization of Radiation Oncologists: Study Based on Structure Survey in Japan.Int J Radiat Oncol Biol Phys 2011. PMID:21470792
  17. Numasaki H, Shibuya H, Nishio M, Ikeda H, Sekiguchi K, Kamikonya N, Koizumi M, Tago M, Ando Y, Tsukamoto N, Terahara A, Nakamura K, Mitsumori M, Nishimura T, Hareyama M, Teshima T, Committee JSTROD: Japanese structure survey of radiation oncology in 2007 with special reference to designated cancer care hospitals.Strahlenther Onkol 2011, 187(3):167-174. PMID:21347636
  18. Saha D, Dunn H, Zhou H, Harada H, Hiraoka M, Mason RP, Zhao D: In vivo Bioluminescence Imaging of Tumor Hypoxia Dynamics of Breast Cancer Brain Metastasis in a Mouse Model. J Vis Exp2011(56). PMID:21989061
  19. Saji S, Hiraoka M, Tokuda Y, Fukui N, Ikeda T: Trends in local therapy application for early breast cancer patients in the Japanese Breast Cancer Society Breast Cancer Registry during 2004-2009. Breast Cancer2012, 19(1):1-3. PMID:22124993
  20. Sakanaka K, Mizowaki T, Arakawa Y, Araki N, Oya N, Takahashi JA, Mikuni N, Miyamoto S, Hashimoto N, Hiraoka M: Hypofractionated stereotactic radiotherapy for acoustic neuromas: safety and effectiveness over 8 years of experience. Int J Clin Oncol 2011, 16(1):27-32. PMID:20830603
  21. Sakanaka K, Mizowaki T, Hiraoka M:Dosimetric Advantage of Intensity-modulated Radiotherapy for Whole Ventricles in the Treatment of Localized Intracranial Germinoma. Int J Radiat Oncol Biol Phys2011. PMID:21640515
  22. Shibuya K, Oya N, Fujii T, Doi R, Nakamura A, Matsuo Y, Mitsumori M, Hiraoka M: Phase II study of radiation therapy combined with weekly low-dose gemcitabine for locally advanced, unresectable pancreatic cancer. Am J Clin Oncol 2011, 34(2):115-119. PMID:20065850
  23. Shiinoki T, Shibuya K, Nakamura M, Nakamura A, Matsuo Y, Nakata M, Sawada A, Mizowaki T, Itoh A, Hiraoka M: Interfractional Reproducibility in Pancreatic Position Based on Four-Dimensional Computed Tomography. Int J Radiat Oncol Biol Phys2011. PMID:21493016
  24. Takayama K, Mizowaki T, Negoro Y, Norihisa Y, Hiraoka M: Impact of double-balloon rectal catheter use in external-beam radiotherapy for prostate cancer. Int J Clin Oncol2011, 16(1):50-56. PMID:20922449
  25. Toi M, Winer EP, Inamoto T, Benson JR, Forbes JF, Mitsumori M, Robertson JF, Sasano H, von Minckwitz G, Yamauchi A, Klimberg VS: Identifying gaps in the locoregional management of early breast cancer: highlights from the kyoto consensus conference. Ann Surg Oncol 2011, 18(10):2885-2892. PMID:21431404
  26. Toita T, Kato S, Niibe Y, Ohno T, Kazumoto T, Kodaira T, Kataoka M, Shikama N, Kenjo M, Tokumaru S, Yamauchi C, Suzuki O, Sakurai H, Numasaki H, Teshima T, Oguchi M, Kagami Y, Nakano T, Hiraoka M, Mitsuhashi N:Prospective Multi-Institutional Study of Definitive Radiotherapy With High-Dose-Rate Intracavitary Brachytherapy in Patients With Nonbulky (<4-cm) Stage I and II Uterine Cervical Cancer (JAROG0401/JROSG04-2). Int J Radiat Oncol Biol Phys 2011. PMID:21470794
  27. Toita T, Ohno T, Kaneyasu Y, Kato T, Uno T, Hatano K, Norihisa Y, Kasamatsu T, Kodaira T, Yoshimura R, Ishikura S, Hiraoka M, Group ftJRTS: A Consensus-based Guideline Defining Clinical Target Volume for Primary Disease in External Beam Radiotherapy for Intact Uterine Cervical Cancer.Jpn J Clin Oncol 2011, 41(9):1119-1126. PMID:21875938
  28. Tomita N, Toita T, Kodaira T, Shinoda A, Uno T, Numasaki H, Teshima T, Mitsumori M: Changing trend in the patterns of pretreatment diagnostic assessment for patients with cervical cancer in Japan. Gynecol Oncol 2011. PMID:21945554
  29. Ueda M, Kudo T, Mutou Y, Umeda IO, Miyano A, Ogawa K, Ono M, Fujii H, Kizaka-Kondoh S, Hiraoka M, Saji H: Evaluation of [(125) I]IPOS as a molecular imaging probe for hypoxia-inducible factor-1-active regions in a tumor: Comparison among SPECT/CT imaging, autoradiography, and immunohistochemistry. Cancer Sci 2011. PMID:21824221
2010
  1. ABE, E., MIZOWAKI, T., NORIHISA, Y., NARITA, Y., MATSUO, Y., NARABAYASHI, M., NAGATA, Y. & HIRAOKA, M. Impact of multileaf collimator width on intraprostatic dose painting plans for dominant intraprostatic lesion of prostate cancer. J Appl Clin Med Phys, 11, 3193, 2010.
  2. CHEN, F., MATSUO, Y., YOSHIZAWA, A., SATO, T., SAKAI, H., BANDO, T., OKUBO, K., SHIBUYA, K. & DATE, H. Salvage Lung Resection for Non-small Cell Lung Cancer After Stereotactic Body Radiotherapy in Initially Operable Patients. J Thorac Oncol, 5, 1999-2002, 2010.
  3. FUJITA, Y., IHARA, M., USHIKI, T., HIRAI, H., KIZAKA-KONDOH, S., HIRAOKA, M., ITO, H. & TAKAHASHI, R. Early protective effect of bone marrow mononuclear cells against ischemic white matter damage through augmentation of cerebral blood flow. Stroke, 41, 2938-43, 2010.
  4. HARADA, H. & HIRAOKA, M. 2010. Hypoxia-Inducible Factor 1 in Tumor Radioresistance. Current Signal Transduction Therapy, 5, 188-196. HIRAOKA, M., MATSUO, Y. & TAKAYAMA, K. Stereotactic body radiation therapy for lung cancer: achievements and perspectives. Jpn J Clin Oncol, 40, 846-54, 2010.
  5. KOMATSU, H., HARDA, H., TANABE, K., HIRAOKA, M. & NISHIMOTO, S.-I. Indolequinone-rhdol Conjugate as a fluorescent probe for hypoxic cells:enzymatic activation and fluorescence properties. Med Chem Comm, 1, 50-53, 2010.
  6. KUDO, T., UEDA, M., KONISHI, H., KAWASHIMA, H., KUGE, Y., MUKAI, T., MIYANO, A., TANAKA, S., KIZAKA-KONDOH, S., HIRAOKA, M. & SAJI, H. PET Imaging of Hypoxia-Inducible Factor-1-Active Tumor Cells with Pretargeted Oxygen-Dependent Degradable Streptavidin and a Novel (18)F-Labeled Biotin Derivative. Mol Imaging Biol. 2010
  7. LI, Z., KAWASHITA, M., ARAKI, N., MITSUMORI, M., HIRAOKA, M., and DOI, M. Magnetic SiO 2 gel microspheres for arterial embolization hyperthermia. Biomedical Materials, 5, 065010, 2010.
  8. LI, Z., KAWASHITA, M., ARAKI, N., MITSUMORI, M., HIRAOKA, M. & DOI, M. Magnetite nanoparticles with high heating efficiencies for application in the hyperthermia of cancer. Materials Science and Engineering: C, 30, 990-996, 2010.
  9. MATSUO, Y., NAKAMOTO, Y., NAGATA, Y., SHIBUYA, K., TAKAYAMA, K., NORIHISA, Y., NARABAYASHI, M., MIZOWAKI, T., SAGA, T., HIGASHI, T., TOGASHI, K. & HIRAOKA, M. 2010a. Characterization of FDG-PET images after stereotactic body radiation therapy for lung cancer. Radiother Oncol, 97, 200-4. , 2010
  10. MIKI, K., ORIDE, K., INOUE, S., KURAMOCHI, Y., NAYAK, R., MATSUOKA, H., HARADA, H., HIRAOKA, M. & OHE, K. Ring-opening metathesis polymerization-based synthesis of polymeric nanoparticles for enhanced tumor imaging in vivo: Synergistic effect of folate-receptor targeting and PEGylation. Biomaterials, 31, 934-42, 2010.
  11. MIYAZAKI, T., KAI, T., ISHIDA, E., KAWASHITA, M. & HIRAOKA, M. Fabrication of yttria microcapsules for radiotherapy from water/oil emulsion. Journal of the Ceramic Society of Japan, 118, 479-482, 2010.
  12. NAKAMURA, M., SAWADA, A., ISHIHARA, Y., TAKAYAMA, K., MIZOWAKI, T., KANEKO, S., YAMASHITA, M., TANABE, H., KOKUBO, M. & HIRAOKA, M. Dosimetric characterization of a multileaf collimator for a new four-dimensional image-guided radiotherapy system with a gimbaled x-ray head, MHI-TM2000. Medical Physics, 37, 4684-4691, 2010.
  13. NAKAMURA, M., SHIBUYA, K., SHIINOKI, T., MATSUO, Y., NAKAMURA, A., NAKATA, M., SAWADA, A., MIZOWAKI, T. & HIRAOKA, M. Positional Reproducibility of Pancreatic Tumors Under End-Exhalation Breath-Hold Conditions Using a Visual Feedback Technique. Int J Radiat Oncol Biol Phys, 79, 1565-1571, 2010.
  14. OGAWA, K., ITO, Y., KARASAWA, K., OGAWA, Y., ONISHI, H., KAZUMOTO, T., SHIBUYA, K., SHIBUYA, H., OKUNO, Y., NISHINO, S., OGO, E., UCHIDA, N., NEMOTO, K., NISHIMURA, Y. & CANCERS, J. W. S. O. G. Patterns of radiotherapy practice for pancreatic cancer in Japan: results of the Japanese Radiation Oncology Study Group (JROSG) survey. Int J Radiat Oncol Biol Phys, 77, 743-50, 2010.
  15. SAKAMOTO, M., MIZOWAKI, T., MITSUMORI, M., TAKAYAMA, K., SASAI, K., NORIHISA, Y., KAMOTO, T., NAKAMURA, E., OGAWA, O. & HIRAOKA, M. Long-term outcomes of three-dimensional conformal radiation therapy combined with neoadjuvant hormonal therapy in Japanese patients with locally advanced prostate cancer. Int J Clin Oncol, 15, 571-577, 2010.
  16. SAKANAKA, K., MIZOWAKI, T., ARAKAWA, Y., ARAKI, N., OYA, N., TAKAHASHI, J., MIKUNI, N., MIYAMOTO, S., HASHIMOTO, N. & HIRAOKA, M. Hypofractionated stereotactic radiotherapy for acoustic neuromas: safety and effectiveness over 8 years of experience. Int J Clin Oncol, 16, 27-32, 2010.
  17. TAKAKURA, T., MIZOWAKI, T., NAKATA, M., YANO, S., FUJIMOTO, T., MIYABE, Y., NAKAMURA, M. & HIRAOKA, M. The geometric accuracy of frameless stereotactic radiosurgery using a 6D robotic couch system. Phys Med Biol, 55, 1-10, 2010.
  18. TAKAYAMA, K., MIZOWAKI, T., NEGORO, Y., NORIHISA, Y. & HIRAOKA, M. Impact of double-balloon rectal catheter use in external-beam radiotherapy for prostate cancer. Int J Clin Oncol, 16, 50-56, 2010.
  19. TOITA, T., OHNO, T., KANEYASU, Y., UNO, T., YOSHIMURA, R., KODAIRA, T., FURUTANI, K., KASUYA, G., ISHIKURA, S., KAMURA, T., HIRAOKA, M. & GROUP, J. C. O. A consensus-based guideline defining the clinical target volume for pelvic lymph nodes in external beam radiotherapy for uterine cervical cancer. Jpn J Clin Oncol, 40, 456-63, 2010.
  20. UEDA, M., KUDO, T., KUGE, Y., MUKAI, T., TANAKA, S., KONISHI, H., MIYANO, A., ONO, M., KIZAKA-KONDOH, S., HIRAOKA, M. & SAJI, H. Rapid detection of hypoxia-inducible factor-1-active tumours: pretargeted imaging with a protein degrading in a mechanism similar to hypoxia-inducible factor-1alpha. Eur J Nucl Med Mol Imaging, 37, 1566-74, 2010.
  21. USHIKI, T., KIZAKA-KONDOH, S., ASHIHARA, E., TANAKA, S., MASUKO, M., HIRAI, H., KIMURA, S., AIZAWA, Y., MAEKAWA, T. & HIRAOKA, M. Noninvasive tracking of donor cell homing by near-infrared fluorescence imaging shortly after bone marrow transplantation. PLoS One, 5, e11114, 2010.
  22. ZHAO, T., HARADA, H., TERAMURA, Y., TANAKA, S., ITASAKA, S., MORINIBU, A., SHINOMIYA, K., ZHU, Y., HANAOKA, H., IWATA, H., SAJI, H. & HIRAOKA, M. A novel strategy to tag matrix metalloproteinases-positive cells for in vivo imaging of invasive and metastatic activity of tumor cells. J Control Release, 144, 109-14, 2010.
  23. 溝脇 尚志, 高山 賢二. 前立腺がんに対する強度変調放射線治療(IMRT)の現状と課題. Rad Fan, 8(12), 49-51, 2010.
  24. 溝脇 尚志, 高山 賢二, 則久 佳毅, 矢野 慎輔, 神波 大己, 井上 貴博, 清水 洋祐, 小川 修, 平岡 眞寛. C期前立腺癌に対する放射線外部照射療法の至適治療ストラテジー:ネオジュバント内分泌療法併用高線量局所外部照射の治療成績. 泌尿器外科, 23(8), 1049-1051, 2010.
  25. 澁谷 景子, 平岡 眞寛. 切除不能膵癌に対する集学的治療-切除不能膵癌に対する放射線治療. 消化器外科, 33(12), 1853-1860, 2010.
  26. 門之園哲哉, 口丸高弘, 近藤科江, 平岡眞寛 すい臓がんの進行とプロドラッグ治療効果の光イメージング. JSMI Report, 3, 19-21, 2010.
2009

1. Harada H, Itasaka S, Kizaka-Kondoh S, et al. The Akt/mTOR pathway assures the synthesis of HIF-1alpha protein in a glucose- and reoxygenation-dependent manner in irradiated tumors. J Biol Chem. Feb 2009;284(8):5332-5342.

2. Harada H, Itasaka S, Zhu Y, et al. Treatment regimen determines whether an HIF-1 inhibitor enhances or inhibits the effect of radiation therapy. Br J Cancer. Mar 2009;100(5):747-757.

3. Hirata N, Fujisawa Y, Tanabe K, Harada H, Hiraoka M, Nishimoto S. Radiolytic activation of a cytarabine prodrug possessing a 2-oxoalkyl group: one-electron reduction and cytotoxicity characteristics. Org Biomol Chem. Feb 2009;7(4):651-654.

4. Kizaka-Kondoh S, Itasaka S, Zeng L, et al. Selective killing of hypoxia-inducible factor-1-active cells improves survival in a mouse model of invasive and metastatic pancreatic cancer. Clin Cancer Res. May 2009;15(10):3433-3441.

5. Kizaka-Kondoh S, Tanaka S, Harada H, Hiraoka M. The HIF-1-active microenvironment: an environmental target for cancer therapy. Adv Drug Deliv Rev. Jul 2009;61(7-8):623-632.

6. Kudo T, Ueda M, Kuge Y, et al. Imaging of HIF-1-active tumor hypoxia using a protein effectively delivered to and specifically stabilized in HIF-1-active tumor cells. J Nucl Med. Jun 2009;50(6):942-949.

7. Makino A, Kizaka-Kondoh S, Yamahara R, et al. Near-infrared fluorescence tumor imaging using nanocarrier composed of poly(L-lactic acid)-block-poly(sarcosine) amphiphilic polydepsipeptide. Biomaterials. Oct 2009;30(28):5156-5160.

8. Matsugi K, Narita Y, Sawada A, et al. Measurement of interfraction variations in position and size of target volumes in stereotactic body radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys. Oct 2009;75(2):543-548.

9. Miki K, Kuramochi Y, Oride K, et al. Ring-opening metathesis polymerization-based synthesis of ICG-containing amphiphilic triblock copolymers for in vivo tumor imaging. Bioconjug Chem. Mar 2009;20(3):511-517.

10. Mitsumori M, Hiraoka M, Inaji H, et al. Impact of radiation therapy on breast-conserving therapy for breast cancer in Japanese women: a retrospective analyses of multi-institutional experience. Kansai Breast Cancer Radiation Therapy Study Group. Oncol Rep. Jun 2009;21(6):1461-1466.

11. Miyabe Y, Narita Y, Mizowaki T, et al. New algorithm to simulate organ movement and deformation for four-dimensional dose calculation based on a three-dimensional CT and fluoroscopy of the thorax. Med Phys. Oct 2009;36(10):4328-4339.

12. Nagata Y, Hiraoka M, Mizowaki T, et al. Survey of stereotactic body radiation therapy in Japan by the Japan 3-D Conformal External Beam Radiotherapy Group. Int J Radiat Oncol Biol Phys. Oct 2009;75(2):343-347.

13. Nakamura M, Narita Y, Matsuo Y, et al. Effect of audio coaching on correlation of abdominal displacement with lung tumor motion. Int J Radiat Oncol Biol Phys. Oct 2009;75(2):558-563.

14. Nakamura M, Narita Y, Sawada A, et al. Impact of motion velocity on four-dimensional target volumes: a phantom study. Med Phys. May 2009;36(5):1610-1617.

15. Nishimura Y, Mitsumori M, Hiraoka M, et al. A randomized phase II study of cisplatin/5-FU concurrent chemoradiotherapy for esophageal cancer: Short-term infusion versus protracted infusion chemotherapy (KROSG0101/JROSG021). Radiother Oncol. Aug 2009;92(2):260-265.

16. Okubo K, Sonobe M, Fujinaga T, et al. Survival and relapse pattern after trimodality therapy for malignant pleural mesothelioma. Gen Thorac Cardiovasc Surg. Nov 2009;57(11):585-590.

17. Ou G, Itasaka S, Zeng L, et al. Usefulness of HIF-1 imaging for determining optimal timing of combining bevacizumab and radiotherapy. Int J Radiat Oncol Biol Phys. Oct 2009;75(2):463-467.

18. Sakamoto T, Oya N, Shibuya K, Nagata Y, Hiraoka M. Dose-response relationship and dose optimization in radiotherapy of postoperative keloids. Radiother Oncol. May 2009;91(2):271-276.

19. Takayama K, Mizowaki T, Kokubo M, et al. Initial validations for pursuing irradiation using a gimbals tracking system. Radiother Oncol. Oct 2009;93(1):45-49.

20. Tanabe K, Harada H, Narazaki M, et al. Monitoring of biological one-electron reduction by (19)F NMR using hypoxia selective activation of an (19)F-labeled indolequinone derivative. J Am Chem Soc. Nov 2009;131(44):15982-15983.

2008
  1. Harada H, Xie X, Itasaka S, Zeng L, Zhu Y, Morinibu A, Shinomiya K, Hiraoka M. Diameter of tumor blood vessels is a good parameter to estimate HIF-1-active regions in solid tumors. Biochem Biophys Res Commun, 373: 533-538, 2008. PMID: 18586004
  2. Isomura M, Oya N, Tachiiri S, Kaneyasu Y, Nishimura Y, Akimoto T, Hareyama M, Sugita T, Mitsuhashi N, Yamashita T, Aoki M, Sai H, Hirokawa Y, Sakata K, Karasawa K, Tomida A, Tsuruo T, Miki Y, Noda T, Hiraoka M. IL12RB2 and ABCA1 genes are associated with susceptibility to radiation dermatitis. Clin Cancer Res, 14: 6683-6689, 2008. PMID: 18927311
  3. Kawashita M, Domi S, Saito Y, Aoki M, Ebisawa Y, Kokubo T, Saito T, Takano M, Araki N, Hiraoka M. In vitro heat generation by ferrimagnetic maghemite microspheres for hyperthermic treatment of cancer under an alternating magnetic field. J Mater Sci Mater Med, 19: 1897-1903, 2008. PMID: 17914614
  4. Kosaka Y, Mitsumori M, Yamauchi C, Narita Y, Hiraoka M. Feasibility of accelerated partial breast irradiation using three-dimensional conformal radiation therapy for Japanese women: a theoretical plan using six patients’ CT data. Breast Cancer, 15: 108-114, 2008. PMID: 18224404
  5. Mitsumori M, Hiraoka M. Current status of accelerated partial breast irradiation. Breast Cancer, 15: 101-107, 2008. PMID: 18224403
  6. Naka K, Narita A, Tanaka H, Chujo Y, Morita M, Inubushi T, Nishimura I, Hiruta J, Shibayama H, Koga M, Ishibashi S, Seki J, Kizaka-Kondoh S, Hiraoka M. Biomedical applications of imidazolium cation-modified iron oxide nanoparticles Polym Adv Technol, 19: 1421-1429, 2008.
  7. Nakamura K, Kodaira T, Shikama N, Kagami Y, Ishikura S, Shibata T, Hiraoka M. Accelerated fractionation versus conventional fractionation radiation therapy for glottic cancer of T1-2N0M0 Phase III study: Japan Clinical Oncology Group study (JCOG 0701). Jpn J Clin Oncol, 38: 387-389, 2008. PMID: 18390558
  8. Nakamura M, Narita Y, Matsuo Y, Narabayashi M, Nakata M, Yano S, Miyabe Y, Matsugi K, Sawada A, Norihisa Y, Mizowaki T, Nagata Y, Hiraoka M. Geometrical differences in target volumes between slow CT and 4D CT imaging in stereotactic body radiotherapy for lung tumors in the upper and middle lobe. Med Phys, 35: 4142-4148, 2008. PMID: 18841867
  9. Nakayama H, Mizowaki T, Narita Y, Kawada N, Takahashi K, Mihara K, Hiraoka M. Development of a three-dimensionally movable phantom system for dosimetric verifications. Med Phys, 35: 1643-1650, 2008. PMID: 18561639
  10. Norihisa Y, Nagata Y, Takayama K, Matsuo Y, Sakamoto T, Sakamoto M, Mizowaki T, Yano S, Hiraoka M. Stereotactic body radiotherapy for oligometastatic lung tumors. Int J Radiat Oncol Biol Phys, 72: 398-403, 2008. PMID: 18374506
  11. Tanabe K, Hirata N, Harada H, Hiraoka M, Nishimoto S. Emission under hypoxia: one-electron reduction and fluorescence characteristics of an indolequinone-coumarin conjugate. Chembiochem, 9: 426-432, 2008. PMID: 18224643
  12. Tanisaka H, Kizaka-Kondoh S, Makino A, Tanaka S, Hiraoka M, Kimura S. Near-infrared fluorescent labeled peptosome for application to cancer imaging. Bioconjug Chem, 19: 109-117, 2008. PMID: 18163535
  13. Yamada K, Akiyama N, Yamada S, Tanaka H, Saito S, Hiraoka M, Kizaka-Kondoh S. Taip2 is a novel cell death-related gene expressed in the brain during development. Biochem Biophys Res Commun, 369: 426-431, 2008. PMID: 18291095
  14. Zeng L, Ou G, Itasaka S, Harada H, Xie X, Shibuya K, Kizaka-Kondoh S, Morinibu A, Shinomiya K, Hiraoka M. TS-1 enhances the effect of radiotherapy by suppressing radiation-induced hypoxia-inducible factor-1 activation and inducing endothelial cell apoptosis. Cancer Sci, 99: 2327-2335, 2008. PMID: 18823375
  15. Zhu SY, Mizowaki T, Norihisa Y, Takayama K, Nagata Y, Hiraoka M. Comparisons of the impact of systematic uncertainties in patient setup and prostate motion on doses to the target among different plans for definitive external-beam radiotherapy for prostate cancer. Int J Clin Oncol, 13: 54-61, 2008. PMID: 18307020
2007
1 Lyshchik A., Higashi T., Asato R., Tanaka S., Ito J., Hiraoka M., Insana M. F., Brill A. B., Saga T., Togashi K.: Cervical Lymph Node Metastases: Diagnosis at Sonoelastography–Initial Experience., Radiology, 247(1):258-67, 2007
2 Matsuo Y., Takayama K., Nagata Y., Kunieda E., Tateoka K., Ishizuka N., Mizowaki T., Norihisa Y., Sakamoto M., Narita Y., Ishikura S., Hiraoka M.: Interinstitutional variations in planning for stereotactic body radiation therapy for lung cancer. Int J Radiat Oncol Biol Phys, 68(2):416-25, 2007
3 Kano H., Takahashi J. A., Katsuki T., Araki N., Oya N., Hiraoka M., Hashimoto N.: Stereotactic radiosurgery for atypical and anaplastic meningiomas. J Neurooncol, 84(1): 41-47, 2007.
4 Yamamoto T., Mizowaki T., Miyabe Y., Takegawa H., Narita Y., Yano S., Nagata Y., Teshima T., Hiraoka M.: An integrated Monte Carlo dosimetric verification system for radiotherapy treatment planning. Phys Med Biol, 52(7): 1991-2008, 2007
5 Nagata Y., Matsuo Y., Takayama K., Norihisa Y., Mizowaki T., Mitsumori M., Shibuya K., Yano S., Narita Y., Hiraoka M.: Current status of stereotactic body radiotherapy for lung cancer., Int J Clin Oncol., 12(1): 3-7, 2007
6 Hiraoka M., Matsuo Y., Nagata Y.: Stereotactic body radiation therapy (SBRT) for early-stage lung cancer, Cancer Radiother, 11(1-2): 32-5, 2007
7 Zeng L., Kizaka-Kondoh S., Itasaka S., Xie X., Inoue M., Tanimoto K., Shibuya K., Hiraoka M: Hypoxia inducible factor-1 influences sensitivity to paclitaxel of human lung cancer cell lines under normoxic conditions., Cancer Sci., 98(9): 1394-401, 2007
8 Hiraga T., Kizaka-Kondoh S., Hirota K., Hiraoka M., Yoneda T.: Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer., Cancer Res, 67(9): 4157-63, 2007
9 Liu J., Harada H., Ogura M., Shibata T., Hiraoka, M.: Adenovirus-mediated hypoxia-targeting cytosine deaminase gene therapy enhances radiotherapy in tumour xenografts., Br J Cancer, 96(12): 1871-1878, 2007
10 Kamino Y., Miura S., Kokubo M., Yamashita I., Hirai E., Hiraoka M., Ishikawa J.: Development of an ultrasmall C-band linear accelerator guide for a four-dimensional image-guided radiotherapy system with a gimbaled x-ray head., Med Phys., 34(5): 1797-1808, 2007
11 Mitsumori M., Zhi-Fan Z., Oliynychenko P., Park J. H., Choi I. B., Tatsuzaki H., Tanaka Y., Hiraoka M.: Regional hyperthermia combined with radiotherapy for locally advanced non-small cell lung cancers: a multi-institutional prospective randomized trial of the International Atomic Energy Agency., Int J Clin Oncol., 12(3): 192-98, 2007
12 Matsui K., Nagata Y., Hiraoka M. : Radiotherapy for Erdheim-Chester disease., Int J Clin Oncol., 12(3): 238-241, 2007.
13 Harada, H., Kizaka-Kondoh, S., Li, G., Itasaka, S., Shibuya, K., Inoue, M., and Hiraoka, M. Significance of HIF-1-active cells in angiogenesis and radioresistance. Oncogene, 26: 7508-7516, 2007.
14 Harada H., Kizaka-Kondoh S., Itasaka S., Shibuya K., Morinibu A., Shinomiya K., Hiraoka M.: The combination of hypoxia-response enhancers and an oxygen-dependent proteolytic motif enables real-time imaging of absolute HIF-1 activity in tumor xenografts., Biochem Biophys Res Commun, 360(4):791-6, 2007
15 Onishi H., Shirato H., Nagata Y., Hiraoka M., Fujino M., Gomi K., Niibe Y., Karasawa K., Hayakawa K., Takai Y., Kimura T., Takeda A., Ouchi A., Hareyama M., Kokubo M., Hara R., Itami J., Yamada K., Araki T.: Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study., J Thorac Oncol, 2(7 Suppl 3): S94-100, 2007
16 Hiraoka M., Ishikura S.: A Japan clinical oncology group trial for stereotactic body radiation therapy of non-small cell lung cancer., J Thorac Oncol., 2(7 Suppl 3): S115-117, 2007
17 Yoshimura K., Kamoto T., Nakamura E., Segawa T., Kamba T., Takahashi T., Nishiyama H., Ito N., Takayama K., Mizowaki T., Mitsumori M., Hiraoka M., Ogawa O.: Health-related quality-of-life after external beam radiation therapy for localized prostate cancer: intensity-modulated radiation therapy versus conformal radiation therapy., Prostate Cancer Prostatic Dis., 10(3): 288-92, 2007
18 Kamino Y., Tsukuda K., Kokubo M., Miura S., Hirai E., Hiraoka M., Ishikawa, J.: Development of a new concept automatic frequency controller for an ultrasmall C-band linear accelerator guide. Med Phys, 34(8): 3243-3248, 2007.
19 Yamauchi C., Mitsumori M., Sai H., Imagunbai T., Negoro Y., Sasaki Y., Hiraoka M., Shikama N., Sasaki S., Takegawa H., Inoue T., Teshima T.: Patterns of Care Study of Breast-conserving Therapy in Japan: Comparison of the Treatment Process between 1995-1997 and 1999-2001 Surveys., Jpn J Clin Oncol., 37(10):737-43, 2007
20 Matsuo Y., Nagata Y., Mizowaki T., Takayama K., Sakamoto T., Sakamoto M., Norihisa Y., Hiraoka M.: Evaluation of mass-like consolidation after stereotactic body radiation therapy for lung tumors. Int J Clin Oncol 2007. 12(5): p. 356-62.
21 Shibuya K, Komaki R, Shintani T, Itasaka S, Ryan A, Jurgensmeier JM, Milas L, Ang K, Herbst RS, O’Reilly MS. Targeted therapy against VEGFR and EGFR with ZD6474 enhances the therapeutic efficacy of irradiation in an orthotopic model of human non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2007 Dec 1;69(5):1534-43.
22 Wu W, Onn A, Isobe T, Itasaka S, Langley RR, Shitani T, Shibuya K, Komaki R, Ryan AJ, Fidler IJ, Herbst RS, O’Reilly MS. Targeted therapy of orthotopic human lung cancer by combined vascular endothelial growth factor and epidermal growth factor receptor signaling blockade. Mol Cancer Ther. 2007 Feb;6(2):471-83.
23 Itasaka S, Komaki R, Herbst RS, Shibuya K, Shintani T, Hunter NR, Onn A, Bucana CD, Milas L, Ang KK, O’Reilly MS. Endostatin improves radioresponse and blocks tumor revascularization after radiation therapy for A431 xenografts in mice. Int J Radiat Oncol Biol Phys. 2007 Mar 1;67(3):870-8.
2006
1 Fujino M., Shirato H., Onishi H., Kawamura H., Takayama K., Koto M., Onimaru R., Nagata Y., Hiraoka M.: Characteristics of patients who developed radiation pneumonitis requiring steroid therapy after stereotactic irradiation for lung tumors., Cancer J., 12(1): 41-6, 2006
2 Harada H., Kizaka-Kondoh S., Hiraoka M.: Antitumor protein therapy; application of the protein transduction domain to the development of a protein drug for cancer treatment., Breast Cancer, 13(1): 16-26,2006
3 Kageyama Y., Sugiyama H., Ayame H., Iwai A., Fujii Y., Huang L. E., Kizaka-Kondoh S., Hiraoka M., Kihara K.: Suppression of VEGF transcription in renal cell carcinoma cells by pyrrole-imidazole hairpin polyamides targeting the hypoxia responsive element., Acta Oncol., 45(3): 317-24, 2006
4 Kawashita M., Sadaoka K., Kokubo T., Saito T., Takano M., Araki N., Hiraoka M.: Enzymatic preparation of hollow magnetite microspheres for hyperthermic treatment of cancer., J Mater Sci Mater Med., 17(7): 605-10, 2006
5 Kubo T., Shibata T., Itoh K., Maetani Y., Isoda H., Hiraoka M., Egawa H., Tanaka K., Togashi K.: Outcome of percutaneous transhepatic venoplasty for hepatic venous outflow obstruction after living donor liver transplantation., Radiology, 239(1): 285-90, 2006
6 Okada T., Miki Y., Fushimi Y., Hanakawa T., Kanagaki M., Yamamoto A., Urayama S., Fukuyama H., Hiraoka M., Togashi K.: Diffusion-tensor fiber tractography: intraindividual comparison of 3.0-T and 1.5-T MR imaging., Radiology, 238(2): 668-78, 2006
7 Oya N., Sasai K., Tachiiri S., Sakamoto T., Nagata Y., Okada T., Yano S., Ishikawa T., Uchiyama T., Hiraoka M.: Influence of radiation dose rate and lung dose on interstitial pneumonitis after fractionated total body irradiation: acute parotitis may predict interstitial pneumonitis., Int J Hematol., 83(1): 86-91, 2006
8 Oya N., Shibuya K., Sakamoto T., Mizowaki T., Doi R., Fujimoto K., Imamura M., Nagata Y., Hiraoka M.: Chemoradiotherapy in patients with pancreatic carcinoma: phase-I study with a fixed radiation dose and escalating doses of weekly gemcitabine., Pancreatology, 6(1-2): 109-16, 2006
9 Sakamoto M., Oya N., Mizowaki T., Araki N., Nagata Y., Takayama K., Takahashi J. A., Kano H., Katsuki T., Hashimioto N., Hiraoka M.: Initial experiences of palliative stereotactic radiosurgery for recurrent brain lymphomas., J Neurooncol., 77(1): 53-8, 2006
10 Shibata T., Shibata T., Maetani Y., Isoda H., Hiraoka M.: Radiofrequency ablation for small hepatocellular carcinoma: prospective comparison of internally cooled electrode and expandable electrode., Radiology, 238(1): 346-53, 2006
11 Tachiiri S., Katagiri T., Tsunoda T., Oya N., Hiraoka M., Nakamura Y.: Analysis of gene-expression profiles after gamma irradiation of normal human fibroblasts., Int J Radiat Oncol Biol Phys, 64(1): 272-9, 2006
12 Kazawa, N., Kitaichi, M., Hiraoka, M., Togashi, K., Mio, N., Mishima, M., Wada, H.: Small cell lung carcinoma: Eight types of extension and spread on computed tomography., J Comput Assist Tomogr, 30(4): 653-61, 2006
13 Kawashita M., Takayama T., Kokubo T., Takaoka G.G., Araki N., Hiraoka M.: Enzymatic Preparation of Hollow Yttrium Oxide Microspheres for In Situ Radiotherapy of Deep-Seated Cancer., J.Am. Ceram. Soc., 89(4): 1347-51, 2006
14 Narabayashi M., Mitsumori M., Araki N., Yamauchi C., Kawamura S., Sakamoto T., Tachiiri S., Oya N., Nagata Y., Hiraoka M., Mise K., Kodama H.: A Case of Metachronous Bilateral Breast Cancer with Bilateral Radiation Pneumonitis After Breast-conserving Therapy., Breast Cancer, 13(3): 313-6, 2006
15 Aoki T., Takahashi J., Ueba T., Oya N., Hiraoka M., Matsui K., Fukui T., Nakashima Y., Ishikawa M., Hashimoto.: Phase Ⅱstudy of nimustine, carboplatin, vincristine, and interferon-β with radiotherapy for glioblastoma multiforme: experience of the Kyoto Neuro-Oncology Group., J Neurosurg., 105(3): 385-91, 2006
16 Kawashita M., Domi S., Saito Y., Aoki M., Ebisawa Y., Kokudo T., Saito T., Takano M., Araki N., Hiraoka M.: In vitro heat generation by ferrimagnetic maghemite microspheres for hyperthemic treatment of cancer under an alternating magnetic field., Submitted to Biomaterials, 2006
17 Kamino Y., Takayama K., Kokubo M., Narita Y., Hirai E., Kawawda N., Mizowaki T., Nagata Y., Nishidai T., Hiraoka M.: Development of a four-dimensional image-guided radiotherapy system with a gimbaled X-ray head., Int J Radiat Oncol Biol Phys., 66(1):271-8, 2006
18 Yoshimura M., Kohzaki M., Nakamura J., Asagoshi K., Sonoda E., Hou E., Prasad R., Wilson S. H., Tano K., Yasui A., Lan L., Seki M., Wood R. D., Arakawa H., Buerstedde J. M., Hochegger H., Okada T., Hiraoka M., Takeda S.: Vertebrate POLQ and POLbeta Cooperate in Base Excision Repair of Oxidative DNA Damage., Mol Cell, 24(1): 115-25, 2006
19 Harada H., Kizaka-Kondoh S., Hiraoka M.: Mechanism of hypoxia-specific cytotoxicity of procaspase-3 fused with a VHL-mediated protein destruction motif of HIF-1alpha containing Pro564., FEBS Lett., 580(24): 5718-22, 2006
20 Nishio T., Kunieda E., Shirato H., Ishikura S., Onishi H., Tateoka K., Hiraoka M., Narita Y., Ikeda M., Goka T.: Dosimetric verification in participating institutions in a stereotactic body radiotherapy trial for stage I non-small cell lung cancer: Japan clinical oncology group trial (JCOG0403)., Phys Med Biol., 51(21): 5409-17, 2006
21 Mitsumori M., Sasaki Y., Mizowaki T., Takayama K., Nagata Y., Hiraoka M., Negoro Y., Sasai K., Kinoshita H., Kamoto T., Ogawa O.: Results of radiation therapy combined with neoadjuvant hormonal therapy for stage III prostate cancer: comparison of two different definitions of PSA failure., Int J Clin Oncol., 11(5): 396-402, 2006
22 Yoshimura K., Kamoto T., Nakamura E., Segawa T., Kamba T., Takahashi T., Nishiyama H., Ito N., Takayama K., Mizowaki T., Mitsumori M., Hiraoka M., Ogawa O.: Health-related quality-of-life after external beam radiation therapy for localized prostate cancer: intensity-modulated radiation therapy versus conformal radiation therapy., Prostate Cancer Prostatic Dis., 2006.
23 Saga T., Kawashima H., Araki N., Takahashi J. A., Nakashima Y., Higashi T., Oya N., Mukai T., Hojo M., Hashimoto N., Manabe T., Hiraoka M., Togashi K.: Evaluation of primary brain tumors with FLT-PET: usefulness and limitations., Clin Nucl Med., 31(12): 774-80., 2006
24 Kosaka Y., Mitsumori M., Araki N., Yamauchi C., Nagata Y., Hiraoka M., Kodama H.: Avascular necrosis of bilateral femoral head as a result of long-term steroid administration for radiation pneumonitis after tangential irradiation of the breast., Int J Clin Oncol., 11(6): 482-6., 2006
25 Hiraoka M., Matsuo Y., Nagata Y.: Stereotactic body radiation therapy (SBRT) for early-stage lung cancer., Cancer Radiother, 2006.
2005
1 Harada H., Kizaka-Kondoh S., Hiraoka M.: Optical imaging of tumor hypoxia and evaluation of efficacy of a hypoxia-targeting drug in living animals., Mol Imaging, 4(3):182-93, 2005
2 Liu J., Qu R., Ogura M., Shibata T., Harada H., Hiraoka M.: Real-time imaging of hypoxia-inducible factor-1 activity in tumor xenografts., J Radiat Res (Tokyo), 46(1): 93-102, 2005
3 Lyshchik A., Higashi T., Asato R., Tanaka S., Ito J., Hiraoka M., Brill A. B., Saga T., Togashi K.: Elastic moduli of thyroid tissues under compression., Ultrason Imaging, 27(2):101-10, 2005
4 Lyshchik A., Higashi T., Asato R., Tanaka S., Ito J., Mai J. J., Pellot-Barakat C., Insana M. F., Brill A. B., Saga T., Hiraoka M., Togashi K.: Thyroid gland tumor diagnosis at US elastography., Radiology, 237(1): 202-11, 2005
5 Mitsumori M., Hiraoka M., Negoro Y., Yamauchi C., Shikama N., Sasaki S., Yamamoto T., Teshima T., Inoue T.: The patterns of care study for breast-conserving therapy in Japan: analysis of process survey from 1995 to 1997., Int J Radiat Oncol Biol Phys, 62(4): 1048-54, 2005
6 Nagata Y., Takayama K., Matsuo Y., Norihisa Y., Mizowaki T., Sakamoto T., Sakamoto M., Mitsumori M., Shibuya K., Araki N., Yano S., Hiraoka M.: Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame., Int J Radiat Oncol Biol Phys., 63(5):1427-31, 2005
7 Nakayama T., Tsuboyama T., Toguchida J., Tanaka C., Oya N., Hiraoka M., Nakamura T.: Recurrence of osteosarcoma after intraoperative radiation therapy., Orthopedics, 28(10): 1195-7, 2005
8 Ogura M., Shibata T., Yi J., Liu J., Qu R., Harada H., Hiraoka M.: A tumor-specific gene therapy strategy targeting dysregulation of the VHL/HIF pathway in renal cell carcinomas., Cancer Sci., 96(5): 288-94, 2005
9 Sai H., Mitsumori M., Araki N., Mizowaki T., Nagata Y., Nishimura Y., Hiraoka M.: Long-term results of definitive radiotherapy for stage I esophageal cancer., Int J Radiat Oncol Biol Phys., 62(5): 1339-44, 2005
10 Sakamoto G., Inaji H., Akiyama F., Haga S., Hiraoka M., Inai K., Iwase T., Kobayashi S., Sakamoto G., Sano M., Sato T., Sonoo H., Tsuchiya S. Watanabe T.: General rules for clinical and pathological recording of breast cancer 2005., Breast Cancer, 12 Suppl: S1-27, 2005
11 Takayama K., Nagata Y., Negoro Y., Mizowaki T., Sakamoto T., Sakamoto M., Aoki T., Yano S., Koga S., Hiraoka M.: Treatment planning of stereotactic radiotherapy for solitary lung tumor., Int J Radiat Oncol Biol Phys., 61(5): 1565-71, 2005
12 Yamauchi C., Mitsumori M., Nagata Y., Kokubo M., Inamoto T., Mise K., Kodama H., Hiraoka M.: Bilateral breast-conserving therapy for bilateral breast cancer: results and consideration of radiation technique., Breast Cancer, 12(2):135-9, 2005
13 Zhang Z., Harada H., Tanabe K., Hatta H., Hiraoka M., Nishimoto S.: Aminopeptidase N/CD13 targeting fluorescent probes: synthesis and application to tumor cell imaging., Peptides, 26(11): 2182-7, 2005
14 Zhu S., Mizowaki T., Nagata Y., Takayama K., Norihisa Y., Yano S., Hiraoka M.: Comparison of three radiotherapy treatment planning protocols of definitive external-beam radiation for localized prostate cancer., Int J Clin Oncol., 10(6): 398-404, 2005
15 Karasawa K., Mitsumori M., Yamauchi C., Gomi K., Kataoka M., Uematsu T., Kodaira T., Yamakawa M., Karasawa K., Watanabe T., Tsujino K., Hiraoka M.: Treatment outcome of breast-conserving therapy in patients with positive or close resection margins: Japanese multi institute survey for radiation dose effect., Breast Cancer, 12(2):91-8, 2005
16 Nishida M., Yasuda S., Murakami K., Yamamura I., Nagata Y., Iizuka T.: Retropharyngeal lymph node metastases from oral cancer: a report of 2 patients., J Oral Maxillofac Surg., 63(3): 410-2, 2005
17 Vasanthan A., Mitsumori M., Park J. H., Zhi-Fan Z., Yu-Bin Z., Oliynychenko P., Tatsuzaki H., Tanaka Y., Hiraoka M.: Regional hyperthermia combined with radiotherapy for uterine cervical cancers: a multi-institutional prospective randomized trial of the international atomic energy agency., Int J Radiat Oncol Biol Phys., 61(1): 145-53, 2005
2004
1 Aoki T.,Nagata Y., Negoro Y., Takayama K., Mizowaki T., Kokubo M., Oya N., Mitsumori M., Hiraoka M.: Evaluation of lung injury after three-dimensional conformal stereotactic radiation therapy for solitary lung tumors., CT appearance. Radiology, 230(1):101-8, 2004
2 Hiraoka M.: Current status of and perspectives on chemoradiotherapy: an introduction., Int J Clin Oncol., 9(6):413, 2004
3 Hiraoka M., Y. Nagata: Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the Japanese experience., Int J Clin Oncol, 9(5): 352-5, 2004
4 Inoue M., Mukai M., Hamanaka Y., Tatsuta M., Hiraoka M., Kizaka-Kondoh S.: Targeting hypoxic cancer cells with a protein prodrug is effective in experimental malignant ascites., Int J Oncol, 25(3):713-20,2004
5 Ishimori T., Saga T., Nagata Y., Nakamoto Y., Higashi T., Mamede M., Mukai T., Negoro Y., Aoki T., Hiraoka M., Konishi J.: 18F-FDG and 11C-methionine PET for evaluation of treatment response of lung cancer after stereotactic radiotherapy., Ann Nucl Med., 18(8): 669-74, 2004
6 Li G., Mitsumori M., Ogura M., Horii N., Kawamura S., Masunaga S., Nagata Y., Hiraoka M.: Local hyperthermia combined with external irradiation for regional recurrent breast carcinoma., Int J Clin Oncol., 9(3): 179-83, 2004
7 Liu J., Shibata T., Qu R., Ogura M., Hiraoka M.: Influences of the p53 status on hypoxia-induced gene expression., J Radiat Res (Tokyo), 45(2): 333-9, 2004
8 Masunaga S., Nagasawa H., Hiraoka M., Sakurai Y., Uto Y., Hori H., Nagata K., Suzuki M., Maruhashi A., Kinashi Y., Ono K.: Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate TX-2060 as a 10B-carrier in boron neutron capture therapy., Anticancer Res., 24(5A): 2975-83, 2004
9 Okumura S., Mitsumori M., Yamauchi C., Kawamura S., Oya N., Nagata Y., Hiraoka M., Kokubo M., Mise K., Kodama H.: Feasibility of breast-conserving therapy for macroscopically multiple ipsilateral breast cancer., Int J Radiat Oncol Biol Phys., 59(1): 146-51, 2004
10 Onishi H., Araki T., Shirato H., Nagata Y., Hiraoka M., Gomi K., Yamashita T., Niibe Y., Karasawa K., Hayakawa K., Takai Y., Kimura T., Hirokawa Y., Takeda A., Ouchi A., Hareyama M., Kokubo M., Hara R., Itami J., Yamada K.: Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study., Cancer, 101(7):1623-31, 2004
11 Sai H., Mitsumori M., Yamauchi C., Araki N., Okumura S., Nagata Y., Nishimura Y., Hiraoka M.: Concurrent chemoradiotherapy for esophageal cancer: comparison between intermittent standard-dose cisplatin with 5-fluorouracil and daily low-dose cisplatin with continuous infusion of 5-fluorouracil., Int J Clin Oncol., 9(3):149-53, 2004
12 Sawada A., Yoda K., Kokubo M., Kunieda T., Nagata Y., Hiraoka M.: A technique for noninvasive respiratory gated radiation treatment system based on a real time 3D ultrasound image correlation: a phantom study., Med Phys., 31(2): 245-50, 2004
13 Shibata T.,Fujimoto Y., Jin M. J.,Hiraoka M.: Transcatheter arterial embolization for large pancreaticoduodenal artery aneurysm with mechanically detachable coils., Cardiovasc Intervent Radiol., 27(2): 169-71, 2004
14 Shibata T.,Shibata T.,Maetani Y.,Kubo T.,Itoh K.,Togashi K.,Hiraoka M.: Transthoracic percutaneous radiofrequency ablation for liver tumors in the hepatic dome., J Vasc Interv Radiol., 15(11): 1323-7, 2004
15 Masunaga S., Nagasawa H., Hiraoka M., Sakurai Y., Uto Y., Hori H., Nagata K., Suzuki M., Maruhashi A., Kinashi Y., Ono K. The usefulness of 2-nitroimidazole-sodium borocaptate-10B conjugates as 10B-carriers in boron neutron capture therapy., Appl Radiat Isot., 61(5): 953-8,2004
16 Tabuena R. P., Matsumoto H., Mio T., Nagata Y., Mishima M.: Metastatic tumor in the right atrium., Intern Med., 43(5): 445-6, 2004
2003
1 Shibamoto Y., Hayabuchi N., Hiratsuka J., Tokumaru S., Shirato H., Sougawa M., Oya N., Uematsu Y., Hiraoka M.: Is Whole-Brain Irradiation Necessary for Primary Central Nervous System Lymphoma? Patterns of Recurrence after Partial-Brain Irradiation., Cancer, 97(1): 128-133, 2003
2 Inakoshi H., Kanamori R., Tsuchida E., Sakai K., Shibamoto Y., Wakushima H., Ogawa Y., kobayashi M., Obara, T.: Multivariate Analysis of Dissemination Reapse of Medulloblastoma and Estimation of Its Time Parameter for Craniospinal Irradiation., Radiation Medicine, 21(1): 37-45, 2003
3 Kinoshita K., Teshima T., Ohno Y., Inoue T., Yamashita T., Hiraoka M., Mitsuhashi N. , Sumi M.: Logical checking function increases the accuracy of data entry in the patterns of care study., Strahlenther Onkol., 179(2): 107-12, 2003
4 Kawashita M., Kokubo T., Hiraoka M.: Ceramic Microspheres for in Situ Treatment of Cancer, Advances in Sciences and Technology. Materials In Clinical Apprications Ⅵ, Techna Srl, 2003.
5 Mizowaki T., Okajima K., Nagata Y., Mitsumori M., Nishimura Y., Shoji K., Asato R., Hiraoka M.: Concurrent chemotherapy and radiotherapy with Low-Dose cisplatin for nasopharyngeal carcinoma., Am. J. Clin. Oncol. (CCT), 26(2): 155-8, 2003
6 Kawashita M., Shineha R., Kim H. M., Kokubo T., Inoue Y., Araki N., Nagata Y., Hiraoka M., Sawada Y.: Preparation of ceramic microspheres for in situ radiotherapy of deep-seated cancer., Biomaterials., 24(17): 2955-2963, 2003.
7 Suzuki M., Nakamatsu K., Kanamori S., Okumura M.: Feasibility Study of the Simultaneous Integrated Boost (SIB) Method for Malignant Gliomas Using Intensity-modulated Radiotherapy (IMRT)., Jpn J Clin Oncol., 33(6): 271-77, 2003
8 Nishimura Y., Nagata K., Katano S., Sai H.: Severe Complication in Advanced Esophageal Cancer Treated with Radiotherapy after Intubation of Esophageal Stents: A Questionnaire Survey of the Japanese Society for Esophageal Diseases., Int J. Radiation Oncology Biol. Phys., 56(5): 1327-32, 2003
9 Shikama N., Sasaki S., Mitsumori M., Hiraoka M., Yamauchi C., Yamamoto T., Teshima T. and Inoue T.: Patterns of Care Study in Japan: Analysis of patients subjected to mastectomy followed by radiotherapy., Jpn. J Clin. Oncol., 33(9):456-62, 2003
10 Ogura M., Mitsumori M., Okumura S., Yamauchi C., Kawamura S., Oya N., Nagata Y., Hiraoka M.: Radiation therapy for brain metastases from breast cancer., Breast Cancer, 10 (4): 349-55, 2003
11 Kizaka-Kondoh S., Inoue M., Harada H., Hiraoka M.: Tumor hypoxia:A target for selective cancer therapy., Cancer Science, 94(12):1021-28, 2003
12 Okamoto T., Shimozuma K., Katsumata N., Koike M., Hisashige A., Tanaka K., Ohsumi S., Saito M., Shikama N., Mitsumori M., Yamauchi C., Watanabe T.: Measuring quality of life in patients with breast cancer:A systematic review of reliable and valid instruments available in Japan., Breast Cancer, 10 (3):204-12, 2003
13 Okumura S.,Mitsumori M., Kokubo M., Yamauchi C., Kawamura S., Oya N., Nagata Y., Hiraoka M.: Late skin and subcutaneous soft tissue changes after 10-Gy boost for breast conseving therapy., Breast Cancer, 10(2):129-33, 2003
14 Ikeda H.: Non-invasive manegement of invasive bladder cancer: Lectures by professor William U. Shipley., Jpn J Clin Oncol, 33 (11): 592-94, 2003
15 Yakami M., Mitsumori M., Sai H., Nagata Y., Hiraoka M., Nishimura Y.: Developmento of severe complications caused by stent placement followed by definitive radiation therapy for T4 esophageal cancer., Int J Clin Oncol., 8(6):395-8, 2003
16 Shibata T.,Yamamoto Y., Yamamoto N.,Maetani Y., Shibata T., Ikai I., Terajima H., Hatano E.., Kubo T., Itoh K., Hiraoka M.: Cholangitis and Liver Abscess after Percutaneous Ablation Therapy for Liver Tumors: Incidence and Risk Factors., J. Vasc. Interv. Radiol., (14): 1535-42, 2003
17 Ogura M., Shibata T., Qu R., Liu J., Yi J., Hiraoka M.: A tumor-specific gene therapy for renal cell carcinomas using a hypoxia-responsive vector system., Int J Radiat Oncol Biol Phys., 57(2 Suppl): S345-6, 2003
18 Aoki T., Nagata Y., Mizowaki T., Kokubo M., Negoro Y., Takayama K., Mitsumori M., Sasai K., Hiraoka M.: Clinical evaluation of dynamic arc conformal radiotherapy for paraaortic lymph node metastasis., Radiotherapy and oncology, 67(1): 113-8, 2003
19 Shikama N., Nishikawa A., Mitsumori M., Hiraoka M., Yamamoto T., Teshima T., Inoue T., Wilson F., Owen J.: Patterns of care study: comparison of process of post-mastectomy radiotherapy (PMRT) in Japan and the USA., Jpn J Clin Oncol., 33(10): 518-21, 2003
2002
1 Nagata Y., Negoro Y., Aoki T., Mizowaki T., Takayama K., Kokubo M., Araki N., Mitsumori M., Sasai K., Shibamoto Y., Koga S., Yano S., Hiraoka M.: Clinical outcomes of 3-D conformal hypofractionated single high dose radiotherapy for one of two lung tumors using a stereotactic body frame., Int. J. Radiat. Oncol. Biol. Phys., 52(4):1041-46, 2002
2 Oya N., Shibamoto Y., Nagata Y., Negoro Y., Hiraoka M.: Postperative radiotherapy for intracranial ependymoma:analysis of prognostic factors and patterns of failure., J. of Neuro-Oncol., 56(1):87-94, 2002
3 Harada H., Hiraoka M., Kizaka-Kondoh S.: Antitumor Effect of TAT-Oxygen-dependent Degradation-Caspase-3 Fusion Protein Specifically Stabilized and Activated in Hypoxic Tumor Cells., Cancer Research, 62(7): 2013-18, 2002
4 Nishimura Y., Suzuki M., Nakamatsu K., Kanamori S., Yagyu Y., Shigeoka H.: Prospective Trial of Concurrent Chemoradiotherapy with Protracted Infusion of 5-Fluorouracil and Cisplatin for T4 Esophageal Cancer With or Without Fistula., Int.J.Radiation Oncol. Biol. Phys., 53(1):134-9, 2002
5 Shibamoto Y., Oya N., Kokubo M., Hiraoka M., Doi, R., Tsujitani M.: Intraoperative Radiotherapy using Hypoxic Cell Sensitizers: Japanese Clinical Trials., Progress in Radio-Oncol. Ⅶ, (Salzburg, Austria, May 15-19.2002):333-9, 2002
6 Hiraoka M., Mitsumori M. and Shibuya K.: Adjuvant radiation therapy following mastectomy for breast cancer., Breast Cancer, 9(3):190-5, 2002
7 Takata M., Tachiiri S., Fujimori A., Larry H. Thompson, Miki Y., Hiraoka M., Takeda S., Yamazoe M.: Conserved domains in the chicken homologue of BRCA2, Oncogene 21, 1130-34, 2002
8 Hiraoka M., Kokubo M., Yamamoto C., Mitsumori M.: Current Status and Perspectives of Radiation Therapy for Breast Cancer., JMAJ, 45(10):434-39, 2002
2001
1 Araki N., Nagata Y., Fujiwara K., Aoki T., Mitsumori M., Kimura H., Itasaka S., Saitou H., Hiraoka M., Kawashita M., Kokubo T.: Evaluation of glass microspheres for intra-arterial radiotherapy in animal kidneys., Int. J. Radiat. Oncol. Biol. Phys., 49(2): 459-63, 2001
2 Negoro Y., Nagata Y., Aoki T., Mizowaki T., Araki N., Takayama K., Kokubo M., Yano S., Koga Y., Sasai K., Shibamoto Y., Hiraoka M.: The effectiveness of an immobilization device in conformal radiotherapy for lung tumor: reduction of respiratory tumor movement and evaluation of daily set-up accuracy., Int J Radiat Oncol Biol Phys., 50(4): 889-98, 2001
3 Horii N., Nishimura Y., Okuno Y., Kanamori S., Hiraoka M., Shimada Y., Imamura M.: Impact of neoadjuvant chemotherapy on Ki-67 and PCNA labeling indices for esophageal squamous cell carcinomas., Int.J. Radiation Oncology Biol. Phys.,49(2):527-32, 2001
4 Mizowaki T., Araki N., Nagata Y., Negoro Y., Aoki T., Hiraoka M.: The use of a permanent magnetic resonance imaging system for radiotherapy treatment planning of bone metastases., Int. J. Radiat. Oncol. Biol. Phys., 49(2): 605-11, 2001
5 Shibamoto Y., Sasai K., Oya N., Hiraoka M.: Intracranial germinoma : radiation therapy with tumor Volume-based dose selection1., Radiology , 218(2): 452-6, 2001
6 Ueda T., Akiyama N., Sai H., Oya N., Noda M., Hiraoka M., Kizaka-Kondoh S.: c-IAP2 is induced by ionizing radiation through NF-κB binding sites., FEBS Letters , 491(1-2): 40-4, 2001
7 Tamai K., Mitsumori M., Fujishiro S., Kokubo M., Oya N., Nagata Y., Sasai K., Hiraoka M., Inamoto T.: A case of allergic reaction to surgical metal clips inserted for postoperative boost irradiation in a patient undergiong breast-conserving therapy., Breast Cancer, 8(1): 90-2, 2001
8 Yu H., Mitsumori M., Nagata Y., Katakura Y., Kokubo M., Oya N., Fujishiro S., Sasai K., Hiraoka M., Kan N.: Meningeal carcinomatosis in patients with breast cancer : Report of 8 Patients., Breast Cancer, 8(1): 74-78, 2001
9 Hiraoka M., Mitsumori M., Nagata Y., Horii N., Kanamori S., Kimura H., Okumura S., Okuno Y., Koishi M., Masunaga S., Akuta K., Nishimura Y.: Current status of clinical hyperthermic oncology in Japan., Thermotherapy for neoplasia, inflammation, and pain, Springer, 2001
10 Koishi M., Yokota S., Mae T., Nishimura Y., Kanamori S., Horii N., Shibuya K., Sasai K., Hiraoka M.: The effects of KNK437, a novel inhibitor of heat shock protein synthesis, on the acquisition of thermotolerance in a murine transplantable tumor in vivo., Clin. Cancer Res.,7(1): 215-9, 2001
11 Kokubo M., Nagata Y., Nishimura Y., Kimura H., Shoji K., Asato R., Sasai K., Hiraoka M.: Concurrent chemoradiotherapy for oropharyngeal carcinoma., Am. J. Clin. Oncol.(CCT), 24(1): 71-76, 2001
12 Imai A., Teshima T., Ohno Y., Inoue T., Yamashita T., Mitsuhashi N., Hiraoka M., Sumi M., the Japanese PCS Working Group: The future demand for and structural problems of Japanese radiotherapy., Jpn. J. Clin. Oncol., 31(4): 135-41, 2001
13 Tingyi Xia, Qingxuan Sun, Xiaoli Shi, Naibin Fan, Hiraoka M.: Relationship between thermal parameters and tumor response in hyperthermia combined with radiation therapy., Int. J. Clin. Oncol., 6: 138-42, 2001
14 Oya N., Sasai K., Shibata T., Takagi T., Shibuya K., Koike s., Nojima K., Fukusawa Y., Ando K., Hiraoka M.: Time course of reoxygenation in experimental murine tumors after Carbon-beam and X-ray irradiation., J. Radiat. Res., 42(2): 131-41, 2001
15 Hayashi M., Teshima T., Tanisada K., Ohno Y., Inoue T., Hiraoka M., Yamashita T., Mitsuhashi N., Sumi M., Japanese working group: Automatic search for optimal conditions in clinical studies., Anticancer Res., 21: 1371-74, 2001
16 Sakamoto T., Kokubo M., Sasai K., Chin K., Jun A. Takahashi, Nagata Y., Hiraoka M.: Central neurogenic hyperventilation with primary cerebral lymphoma: A case report., Rad. Med., 19(4):209-13, July-August 2001
17 Sasai K., Yamabe H., Dodo Y., Kashii S., Nagata Y. and Hiraoka H.: Non-Hodgkin’s lymphoma of the ocular adnexa., Taylor Francis, 40(4):485-90, 2001
18 Hori T., Kodama H., Nishimura S., Hatano T., Okamura R., fujii K., Kudo T., Inamoto T., Sawai K., Kobayashi M., Ogawa H., Yoshimura N., Hiraoka M.: A randomized study comparing oral and standard regimens for metastatic breast cancer., Oncol. Reports, 8(5), 1067-71, 2001
19 Fujimori A., Tachiiri S., Sonoda E., Larry H. Thompson, Pawan Kumar Dhar, Hiraoka M., Takeda S., Yong Zhang., Michael Reth ,Takata M.: Rad52 partially substitutes for the Rad51 paralog XRCC3 in maintaining chromosomal integrity in vertebrate cells., The EMBO Journal, 20(19): 5513-20, 2001
20 Mitsumori M., Shibata T.,Nagata Y.,Hiraoka M., Hasegawa M.,Nagae H., Kito K.: Time Course Change of the Heart-generating Capability of Dextran Magnetite Complex (DM) in vivo, Jpn., J. Hyperthermic Oncol., .17(2):85-92, 2001June
21 Kokubo M., Mitsumori M., Yamamoto C., Fujishiro S., Mise K., Kodama H., Nagata Y. and Hiraoka M.: Impact of boost irradiation with surgically placed radiopaque clips on lical control in breast-conseving therapy., Breast Cancer, 8(3): 222-28, 2001
22 Hinata H., Inakoashi H., Sakai K., Ogawa Y., Kobayashi M., Wakushima H., obara T., Shibamoto Y.: Estimation of Time Parameter of LQ-model in Fractionated Radiotherapy of Medulloblastoma, Radiation Medicine, 19(2):61-70, 2001
23 Kokubo M., Mitsumori M., Kanehira K., Inamoto T.,Mise K., Kodama H., Yamabe H., Hiraoka M.: Results of breast-conserving therapy for ductal carcinoma in situ:The Kyoto University experiences, Breast Cancer, 8(2):153-57, 2001
24 Oya N., Kokubo M, Mizowaki T, Shibamoto Y, Nagata Y, Sasai K, Nishimura Y, Tsuboyama T, Toguchida J, Nakamura T, Hiraoka M.: Defenitive intraoperative very high-dose radiotherapy for localized osteosarcoma in extremities., Int. J. Radiation Oncology Biol. Phys., 51(1):87-93, 2001
25 Umetani K., Itasaka S., Ogura M., Kimura H., Hiraoka M.: Synchrotron Radiation Microangiography System for Observation of Blood Flow in Murine Tumor Vasculature., Bioimages, 9(3-4): 97-106, December 2001
26 Tsukiyama I., Katano S., Shimizu H., Nomoto Y., Shoji K., Hiraoka M., Mitsumori M., Tanaka Y., Nagata K., Fuwa N., Mitsuhashi N., Sakurai H.: Multi-institutional Phase I and ⅡTrial of Simultaneous Intracavitary Hyperthermia and Brachytherapy for Advanced Esophageal Cancer, J Brachytherapy Int, 17: 299-308, 2001
27 Hayashi M., Teshima T., Tanisada K., Ohno Y., Inoue T., Hiraoka M., Yamashita T., Mitsuhashi N., Sumi M.: Automatic search for optimal conditions in clinical studies., Anticancer Res., 21(2B): 1371-4, 2001
28 Imai A., Teshima T., Ohno Y., Inoue T., Yamashita T., Mitsuhashi N., Hiraoka M., Sumi M.: The future demand for and structural problems of Japanese radiotherapy., Jpn J Clin Oncol., 31(4): 135-41, 2001
29 Xia T., Sun Q., Shi X., Fan N., Hiraoka M.: Relationship between thermal parameters and tumor response in hyperthermia combined with radiation therapy., Int J Clin Oncol., 6(3): 138-42, 2001
2000
1 Zhu J.L., Nagata Y., Kanamori S., Mitsumori M., Okuno Y., Horii N., Nishimura Y., Masunaga S., Hiraoka M.: Prelimimary Clinical Results of Locoregional Hyperhermia for Primary and Secondary Bone Tumors., Jpn. J. Hyperther. Oncol. 16: 17-26, 2000
2 Nagata Y., Araki N., Kimura H., Fujiwara K., Okajima K., Aoki T., Mitsumori M., Sasai K., Hiraoka M., Higuchi T., Fujii S.: Neoadjuvant chemotherapy by transcatheter arterial infusion method for uterine cervical cancer., JVIR 11(3): 313-19, 2000
3 Tanisada K., Teshima T., Ikeda H., Abe M., Owen J.B., Hanks G.E., Yamashita T., Nishio M., Yamada S., Sakai K., Hiraoka M., Hirokawa Y., Oguchi M., Inoue T.: A preliminary outcome analysis of the patterns of care study in Japan for esophageal cancer patients with special reference to age : Non surgery group., Int. J. Radiat. Oncol. Biol. Phys., 46(5): 1223-33, 2000
4 Fujishiro S., Mitsumori M., Kokubo M., Nagata Y., Sasai K., Mise K., Kodama H., Hiraoka M.: Cosmetic results and complications after breast conseving therapy for early breast cancer., Breast Cancer, 7: 57-63, 2000
5 Sasai K., Nagata Y., Hiraoka M.: Is the linear-quadratic formula available in stereotactic radiosurgery or hypofractionated radiotherapy? The problem of uncertainty of the a/b ratio in the LQ formula., Int. J. Radiat. Oncol. Biol. Phys., 47: 1157-58, 2000
6 Sasai K., Yamabe H., Kokubo M., Shibata T., Oya N., Nagata Y., Hiraoka M.: Head and neck stages I and II extranodal non-Hodgkin’s lymphomas:Head and neck stages I and II extranodal non-Hodgkin’s lymphomas:REALclassification and selection for treatment modality., Int. J. Radiat. Oncol. Biol. Phys.,48(1): 153-60, 2000
7 Nagata Y., Nishidai T., Hiraoka M.: Development of a CT simulator and its current clinical situations., J. Jpn. Soc. Ther. Radiol. Oncol., 12: 95-108, 2000
8 Kokubo M., Sasai K., Shibamoto Y., Oya N., Mitsumori M., Jun A. Takahashi, Hashimoto N., Hiraoka M.: Long-Term Results of Radiation Therapy for Pituitary Adenoma., J Neurooncol ,47(1):79-84, 2000
9 Fujiwara K., Hayakawa K., Nagata Y., Hiraoka M., Nakamura T., Shimizu Y., Ikada Y.: Experimental Embolization of Rabbit Renal Arteries to Compare the Effects of Poly L-lactic Acid Microspheres With and Without Epirubicin Release Against Intraarterial Injection of Epirubicin., Cardiovasc Intervent Radiol, 23(3):218-223, 2000
10 Kokubo M., Nishimura Y., Shibamoto Y., Sasai K., Hosotani R., Imamura M., Hiraoka M.: Concurrent chemoradiotherapy combined with intraoperative radiotherapy for locally advanced pancreatic cancer:A feasibility study.. Oncology Reports,7(4):773-76, 2000
11 Xie X., Sasai K., Shibuya K., Tashiiri S., Nihei K., Ohnishi T., Hiraoka M.,: P53 status plays no role in radiosensitizing effects of SN-38, a camptothecin derivative., Cancer-Chemother-Pharmacol., 45(5):362-8, 2000
12 Kokubo M., Shibamoto Y., Jun A Takahashi, Sasai K., Oya N., Hashimoto N., Hiraoka M.: Efficacy of conventional radiotherapy for recurrent meningioma., Journal of Neuro-Oncology, 48(1):51-55,2000
13 Mizowaki T., Nagata Y., Okajima K., Kokubo M., Negoro Y., Araki N., Hiraoka M.: Reproducibility of geometric distortion in magnetic resonance imaging based on phantom studies., Radiotherapy and Oncology, 57(2): 237-242, 2000
14 Hiraoka M.,Mitsumori M., Nagata Y.,Horii N., Kanamori S., Kimura H., Okumura S., Okuno Y., Koishi M., Masunaga S., Akuta K., Nishimura Y.: Current Status of Clinical Hyperthemic Oncology in Japan. Thermotherapy for Neoplasia, Inflammation, and Pain,Springer, 471-479,2000
15 Kokubo, M., Nishimura, Y., Shibamoto, Y., Sasai, K., Kanamori, S., Hosotani, R., Imamura, M., Hiraoka M.: Analysis of the Clinical Benefit of Intraoperative Radiotherapy in Patients undergoing Macroscopically Curative Resection for Pancreatic Cancer., Int. J. Radiat. Oncol. Biol. Phys., .48(4):1081-87, 2000
16 Miyakoshi J., Yoshida M., Shibuya K., Hiraoka M.: Exposure to Strong Magnetic Fields at Power Frequency Potentiates X-ray-induced DNA Strand Breaks., J. of Rad. Res., 41(3):293-302, 2000
17 Kokubo, M., Mitsumori, M., Ishikura, S., Nagata, Y., Fujishiro, S., Inamoto, T., Mise, K., Kodama, H., Sasai, K., Hiraoka M.: Results of Breast-Conserving Therapy for Early Stage Breast Cancer: Kyoto University Experiences., Am. J. Clin. Oncol (CCT), 23(5):499-505,2000
18 Noma S., Mizowaki T., Kubo T., Kirihara M., Akasaka Y, Taniguchi T., Sano A., Kuroda Y.: Marking a small pulmonary nodule with a new point marker for thoracoscopic resection., Jpn J Clin. Radiol., 45(1):79-84, 2000
19 Mizowaki T., Yoden E., Nishimura S., Kobashi Y., Kirihara M., Akasaka Y., Okamoto Y., Murakami M., Noma S., Kuroda Y., Nakajima T.: Stereotactic biopsy of non-palpable breast lesions with microcalcifications., Jpn J Breast Cancer, 15(4):428-35, 2000
20 Okamoto Y., Murakami M., Kuroda M., Mizowaki T., Nakajima T., Kusumi F., Hajiro K., Matsusue S., Takeda H., Kobashi, Y.: Mismatched clinicopathological response after concurrent chemoradiotherapy for thoracic esophageal cancer., Dis Esophagus, 13(1): 80-86, 2000
21 Tachiiri S., Sasai K., Oya N., Hiraoka M.: Enhanced Cell Killing by Overexpression of Dominant-negativePhosphatidylinositol 3-Kinase Subunit, Δp85, Following Genotoxic Stresses., JapaneseJournal of Cancer Research, 91(12):1314-18, December 2000
22 Tsuboyama T., Toguchiba J., Kotoura Y., Kasahara K., Hiraoka M., Nakamura T.: Intra-operative radiation therapy for osteosarcoma in the extremities., Int. Orthopaedics(SICOT), 24(4): 202-7, 2000
23 Hiraoka M.,Mitsumori M., Horii N., Ohno S., Tanaka Y., Kotsuka Youji., Senior Member IEEE, Sugimachi K.: Development of RF and Microwave Heating Equipment and Clinical Applications to Cancer Treatment in Japan., IEEE Transaction on Microwave Theory and Techniques, .48(11): 1789-99, Nov. 2000
24 Nishimura M., Tsukahara H., Hiraoka M., Osaka Y., Ohshima Y., Tanizawa A., Mayumi M.: Systemic inflammatory response syndrome and acute renal failure associated with Hemophilus influenzae septic meningitis., Am J Nephrol., 20(3): 208-11, 2000
25 Nihei K., Mitsumori M., Ishigaki T., Fujishiro S., Kokubo M., Nagata Y., Sasai K., Hiraoka M.: Determination of optimal radiation energy for different breast sizes using CT-simulator [correction of simulatior] in tangential breast irradiation., Breast Cancer, 7(3): 231-6, 2000
1999
1 Nishimura Y., Yokoe Y., Nagata Y., Okajima K., Nishida M. and Hiraoka M.: High-dose-rate brachytherapy using molds for oralcavity cancer., Int. J. Clin. Oncol., 3: 351-56, 1998
2 Teshima T., Ikeda H., Abe M., Hanks G.E., Owen J.B., Oguchi M., Hirokawa Y., Hiraoka M., Nishio M., Yamashita T., Naito A., Okazaki Y., Inoue T.: Patterns of care study of radiation therapy for utereine cervix cancer in Japan: The influence of age on the process., Int. J. Clin. Oncol., 4: 9-16, 1999
3 Yamamoto M., Nagata Y., Okajima K., Ishigaki T., Murata R., Mizowaki T., Kokubo M. and Hiraoka M.: Differences in target outline delineation from CT scans of brain tumours using different methods and different observers., Radiother. Oncol., 50(2):151-56, 1999
4 Nagata Y., Okajima K., Kokubo M., Kanamori S., Fujiwara K., Mizowaki T., Sasai K., Hiraoka M., Kataoka N., Konishi I.: Clinical results of transcatheter arterial infusion for uterine cervical cancer., Am. J. Clin. Oncol., 22(1): 97-102, 1999
5 Tanisada K., Teshima T., Inoue T., Owen J.B., Hanks G.E., Abe M., Ikeda H., Sato S., Kawachi K., Yamashita T., Nishio M., Hiraoka M., Hirokawa Y., Oguchi M. and Masuda K.: National average for the process of radiation therapy in Japan by Patterns of Care Study., Jpn. J. Clin. Oncol., 29(4): 209-13, 1999
6 Kanamori S., Nishimura Y., Kokubo M., Sasai K., Hiraoka M., Shibamoto Y., Hosotani R., Imamura M., Abe M.: Tumor response and patterns of failure following intraoperative radiotherapy for unresectable pancreatic cancer; Evaluation by computed tomography., Acta Oncolologica, 38(2): 215-20, 1999
7 Ishikawa S., Nagata Y., Mitsumori M., Sasai K., Kokubo M., Hiraoka M., Tanaka T., Fukumoto M.: Primary large cell carcinoma of the submandibular gland., Int. J. Clin. Oncol., 4: 189-92, 1999
8 Shibamoto Y., Sasai K., Oya N., Hiraoka M.: Systemic chemotherapy with vincristine, cyclophophamide, doxorubicin and predonisolone following radiotherapy for primary central nervous system lymphoma: a phase II study., J. Neuro-oncol., 42(2): 161-67, 1999
9 Kanamori S., Nishimura Y., Okuno Y., Horii N., Saga T., Hiraoka M.: Induction of vascular endothelial growth factor (VEGF) by hyperthermia and/or an angiogenesis inhibitor., Int. J. of Hyperthermia, 15(4): 267-78, 1999
10 Okuno Y., Nishimura Y., Kashu I., Ono K., Hiraoka M.: Prognostic values of proliferating cell nuclear antigen(PCNA) and LI-67 for radiotherapy of esophageal squamous cell carcinomas., Brit. J. Cancer, 80(3-4): 387-95, 1999
11 Guo G.Z., Sasai K., Oya N., Shibata T., Shibuya K., Hiraoka M.: A significant correlation between clonogenic radiosensitivity and the simultaneous assessment of micronucleus and apoptotic cell frequencies., Int. J. Radiat. Biol., 75(7): 857-864, 1999
12 Nishimura Y., Okuno Y., Ono K., Nagata Y., Hiraoka M.: External beam radiation therapy with or without high-dose-rate intraluminal brachytherapy for patients with superficial esophageal carcinoma., Cancer, 86(2): 220-28, 1999
13 Saitoh H., Nagata Y., Mitsumori M., Kokubo M. and Hiraoka M.: Angiographic changes in uterine cervical cancer guring the course of transarterial infusion chemotherapy., Radiat. Medicine, 17(4): 305-9, 1999
14 Shibuya K., Sasai K., Xie X., Utsumi H., Shibata T., Hiraoka M.: Detection of hypoxic cells inmurine tumors using the comet assay: comparison with a conventional radiobiological assay., Jpn. J. Cancer Res., 90(8): 880-86, 1999
15 Mitsumori M., Hiraoka M., Kodama H.: Long-term results of postoperative prophylactic irradiation for node-positive, high-risk breast cancer patients., Breast Cancer, 6(3): 193-200, 1999
16 Shibuya K., Fujibayashi Y., Yoshimi E., Sasai K., Hiraoka M., Welch M.J.: Cytosolic/microsomal redox pathway: a reductive retention mechanism of a PET-oncology tracer, Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) (Cu-PTSM)., Ann. Nucl. Med., 13(5): 287-92, 1999
17 Shibamoto Y., Sasai K., Kokubo M., Hiraoka M.: Salvage radiation therapy for intracranial germinoma recurring after primary chemotherapy., J. Neuro-Oncol., 44(2):181-85, 1999
18 Higashi T., Sakahara H., Torizuka T., Nakamoto Y., Kanamori S., Hiraoka M., Imamura M., Nishimura Y., Tamaki N., Konishi J.: Evaluation of intraoperative radiation therapy for unresectable pancreatic cancer with FDG PET., J Nucl Med., 40(9):1424-33, 1999
19 Fujishiro S., Mitsumori M., Kokubo M., Nagata Y., Sasai K., Kodama H., Hiraoka M.: Evaluation of long-term cosmetic results and complications following breast conseving surgery and radiation therapy for breast cancer., J Jpn. Soc. Ther. Radiol. Oncol. 11: 287-94, 1999
20 Shibuya K., Nagata Y., Itoh T., Okajima K., Murata R., Takagi T., Hiraoka M.: Transcatheter arterial infusion therapy in the treatment of advanced pancreatic cancer: a feasibility study., Cardiovasc Intervent Radiol, 22(3): 196-200, 1999
21 Ikeda T., Akiyama F., Hiraoka M., Inaji H., Ohuchi N., Takatsuka Y., Yoshimoto M.: Surgical Margin Status as a Cause of Local Failure after Breast Conserving Therapy., Breast Cancer, 6(2): 93-97, 1999
1998
1 Ikeda T., Akiyama F., Hiraoka M., Inaji H., Ohuchi N., Takatsuka Y., Yoshimoto M.: The current status of the treatment of ductal carcinoma in situ of Japanese women, especially breast conserving operation in relation to the surgical margin and short term outcome., Breast Cancer, 5(1): 53-58, 1998
2 Guo G.Z., Sasai K., Oya N., Takagi T., Shibuya K. and Hiraoka M.: Simultaneous evaluation of radiation-induced apoptosis and micronuclei in five cell lines., Int. J. Radiat. Biol., 73(3): 297-302, 1998
3 Nagata Y., Fujiwara K., Okajima K., Mitsumori M., Mizowaki T., Ohya N., Hiraoka M., Abe M., Ohura K., Wataya S.: Transcatheter arterial embolization for malignant osseous and soft-tissue sarcomas. I. A rabbit experimental model., Cardiovasc, Intervent. Radiol., 21(3): 205-7, 1998
4 Nagata Y., Mitsumori M., Okajima K., Mizowaki T., Fujiwara K., Sasai K., Nishimura Y., Hiraoka M., Abe M., Shimizu K., Kotoura Y.: Transcatheter arterial mbolization for malignant osseous and soft-tissue sarcomas. II. Clinical results., Cardiovasc, Intervent. Radiol., 21(3): 208-13, 1998
5 Kokubo M., Tsutsui K., Nagata Y., Okajima K., Katakura Y., Negoro Y., Yamamoto M., Hiraoka M.: Radiotherapy combined with transcatheter arterial infusion chemotherapy for locally advanced cervical cancer., Acta Oncolologica, 37(2): 143-49, 1998
6 Teshima T., Abe M., Ikeda H., Hanks G.E., Owen J.B., Hiraoka, M., Hirokawa Y., Oguchi M., Nishio M., Yamashita T., Niibe H., Masuda K., Watanabe S., Inoue T.: Patterns of care study of radiation therapy for esophageal cancer in Japan: Influence of the stratification of institute on the process., Jpn. J. Clin. Oncol., 28(5): 308-13, 1998
7 Fujishiro S., Mitsumori M., Nishimura Y., Okuno Y., Nagata Y., Hiraoka M., Sano T, Marume T., Takayama N.: Increased heating efficiency of hyperthermia using an ultrasound contrast agent: a phantom study., Int. J. Hyperthermia, 14(5): 495-502, 1998
8 Takagi T., Sasai K., Shibamoto Y., Akagi K., Oya N., Shibata T., Kim J., Hiraoka M.: The influence of DNA ploidy of a human tumor cell line on the frequencies of micronuclei or chromosome aberrations after irradiation., Mut. Res. /gen. tox. Env. mut. 418 (1): 49-57, 1998
9 Shibata T., Akiyama N., Noda M., Sasai K., Hiraoka M.: Enhancement of gene expression under hypoxic conditions using fragment of the human vascular endothelial growth factor and the erythropoietin genes., Int. J. Radiat. Oncol. Biol. Phys., 42(4): 913-16, 1998
10 Sasai K, Guo G.Z., Shibuya K., Oya N., Shibata T., Nagata Y., Hiraoka M.: Effects of SN-38 ( an active metabolite of CPT-11) on responses of human and rodent cells to irradiation., Int. J. Radiat. Oncol. Biol. Phys., 42(4), 785-88, 1998
11 Nishio T., Teshima T., Abe M., Ikeda H., Oguchi M., Hirokawa Y., Hiraoka M., Inoue T., Yamashita T., Nishio M., Niibe H., Mori T., Masuda K., Haruuchi H., Inamori K.: Consistency of variables in PCS and JASTRO great area database., Radiation Medicine, 16(6): 449-55, 1998.
12 Tanisada K., Teshima T., Abe M., Ikeda H., Oguchi M., Hirokawa Y., Hiraoka M., Inoue T., Yamashita T., Yamada S., Sakai K., Nishimura T., Chatani M.: Prognostic factors for patients with esophageal cancer treated with radiation therapy in PCS: A preliminary study., Radiation Medicine, 16(6): 461-68, 1998.
13 Konishi I, Nanbu K, Mandai M, Tsuruta Y, Kataoka N, Nagata Y, Mori T.: Tumor response to nepadjyuvant chemotherapy correlates with the expression of P-glycoprotein and PCNA but not GST-kappa in the tumor cells of cervical carcinoma., Gynecol Oncol , 70, 365-71, 1998.
1997
1 Masunaga S., Ono K, Hiraoka M., et al.: Reduction of hypoxic cells in solid tumours induced by mild hyperthermia:special reference to differences in changes in the hypoxic fraction between total and quiescent cell populations., Br.J.Cancer, 76(5): 588-93, 1997
2 Murata R., Nishimura Y., Hiraoka M.: An anti-angiogenic agent (TNP-470) inhibited reoxygenation during fractionated radiotherapy of murine mammary carcinoma., Int J. Radiat. Oncol. Biol. Phys., 37(5): 1107-13, 1997
3 Nagata Y., Hiraoka M., Nishimura Y., Masunaga S., Mitsumori M., Okuno Y., Fujishiro M., Kanamori S., Horii N., Akuta K., Sasai K., Abe M., and Fukuda Y.: Clinical Results of Radiofrequency Hyperthermia for Maglinant Liver Tomors., Int.J.Radiation Oncology Biol. Phys., 38(2): 359-65, 1997
4 Nishimura Y, Hosotani R, Shibamoto Y, Kokubo M, Kanamori S, Sasai K, Hiraoka M, Ohshio G, Imamura M, Takahashi M, Abe M.: External and intraoperative radiotherapy for resectable and unresectable pancreatic cancer: analysis of survival rates and complications., Int J Radiat Oncol Biol Phys., 1;39(1): 39-49, 1997
5 Hosotani R., Kogire M., Hiraoka M., et al.: Results of pancreatectomy with radiation therapy for pancreatic cancer., Hepato- Gastroenterology, Nov-Dec.44(18): 1528-35, 1997
6 Kokubo M., Nagata Y., Mizowaki T., Hiraoka M., Yamamoto M.: Dose-Volume Histogram Analysis of External-Beam Irradiation Combined with IORT for Unresectable Pancreatic Cancer. Veath JM (ed): Intraoperative Radiation Therapy in the Treatment of Cancer., Front Radiat Ther Oncol. Basel, Karger, 31: 177-80, 1997
7 Sasai K., Yamabe H., Tsutsui K., Dodo Y., Ishigaki T., Shibamoto Y., Hiraoka M.: Primary testicular non-Hodgkin’s lymphoma: a clinical study and review of the literature., Am J Clin Oncol, 20(1): 59-62, 1997
8 Sasai K., Murata R., Mandai M., Takahashi M., Ogura Y., Ngata Y., Nishimura Y., Hiraoka M.: Radiation therapy for ocular choroidal neovascularization (phase I/II study): preliminary report., Int J Radiat Oncol Biol Phys., 39(1): 173-8, 1997
9 Nishimura Y., Shibamoto Y., Hosotani R., Ohshio G., Kokubo M., Kanamori S., Sasai K., Hiraoka M., Imamura M., Abe M.: IORT for pancreatic cancer: the Kyoto University experience., Front Radiat Ther Oncol., 31: 184-8, 1997
10 Nakayama M., Sakahara H., Minowa Y., Sasai K., Ishigaki T., Saga T., Nakamoto Y., Yao Z., Hiraoka M., Sakai K., Konishi J.: Value of low-dose gallium-67 imaging in detection of non-Hodgkin’s lymphoma recurrence., Radiat Med., 15(2): 79-83, 1997
11 Kanamori S., Nishimura Y., Kokubo M., Hiraoka M., Abe M.: CT changes following IORT for unresectable pancreatic cancer., Front Radiat Ther Oncol., 31: 189-92, 1997
12 Hiraoka M., Mitsumori M., Kokubo M.: The Roles and Controversies of Radiation Therapy in Breast Conserving Therapy for Breast Cancer., Breast Cancer, 4(3): 127-133, 1997
13 Akagi M., Tsuboyama T., Ikenaga M., Matsusue Y., Hiraoka M., Nakamura T.: Anti-tumour effects of localized hyperthermia on an experimental bone tumour using an intramedullary nail., Int J Hyperthermia, 13(4): 387-400, 1997
1996
1 Masunaga S., Ono K., Mitsumori M., Nishimura Y., Hiraoka M., Akuta K., Nagata Y., Abe M., Takahashi M., Jo S.: Clinical usefulness of determining the rate of thermal clearance within heated tumors., Jpn J Clin Oncol, 26(6): 428-37, 1996
2 Mitsumori M., Hiraoka M., Okuno Y., Nishimura Y., Y.P. Li, Fujishiro S., Nagata Y., Abe M., Koishi M., Sano T., Marume T., Takayama N.: A phase I and II clinical trial of a newly developed ultrasound hyperthermia system with an improved planar transducer., Int J Radiat Oncol Biol Phys, 36(5): 1169-75, 1996
3 Mitsumori M., Hiraoka M., Shibata T., Okuno Y., Nagata Y., Nishimura Y., Abe M., Hasegawa M., Nagae H., Ebisawa Y.: Targeted hyperthermia using dextran magnetite complex: a new treatment modality for liver tumors., Hepatogastroenterology, 43(12): 1431-7, 1996
4 Mizowaki T., Nagata Y., Okajima K., Murata R., Yamamoto M., Kokubo M., Hiraoka M., Abe M.: Development of an MR simulator: experimental verification of geometric distortion and clinical application., Radiology, 199(3): 855-60, 1996
5 Mizowaki T., Nishimura Y., Shimada Y., Nakano Y., Imamura M., Konishi J., M. Hiraoka: Optimal size criteria of malignant lymph nodes in the treatment planning of radiotherapy for esophageal cancer: evaluation by computed tomography and magnetic resonance imaging., Int J Radiat Oncol Biol Phys, 36(5): 1091-8, 1996
6 Murata R., Nishimura Y., Shibamoto Y., Hiraoka M., Abe M.: Changes in cell proliferative parameters of SCCVII and EMT6 murine tumors after single-dose irradiation., Jpn J Cancer Res, 87(6): 662-8 ,1996
7 Murata R., Shibamoto Y., Miyauchi S., Hirohashi M., Takagi T., Sasai K., Oya N., Hiraoka M.: The combined antitumour effect of a new 5-fluorouracil derivative, BOF- A2, and radiation in vivo., Br J Cancer Suppl, 27: S114-6, 1996
8 Nagata Y., Okajima K., Murata R., Mitsumori M., Mizowaki T., Yamamoto M., Hiraoka M., Nishidai T., Nakata M. , Abe M., Sugahara K., Arimura H., Hosoba M., Morisawa H., Kazusa C., Ai D., Kokubo M.: Development of an integrated radiotherapy network system., Int J Radiat Oncol Biol Phys, 34(5): 1105-11, 1996
9 Nishimura Y., Murata R., Hiraoka M.: Combined effects of an angiogenesis inhibitor (TNP-470) and hyperthermia., Br J Cancer, 73(3):270-4 , 1996
10 Nishimura Y., Nagata Y., Okajima K., Mitsumori M., Hiraoka M., Masunaga S., Ono K., Shoji K., Kojima H.: Radiation therapy for T1,2 glottic carcinoma: impact of overall treatment time on local control., Radiother Oncol, 40(3): 225-32, 1996
11 Shibata T., Shibamoto Y., Sasai K., Oya N., Murata R., Takagi T., Hiraoka M., Abe M.: Comparison of in vivo efficacy of hypoxic cytotoxin tirapazamine and hypoxic cell radiosensitizer KU-2285 in combination with single and fractionated irradiation., Jpn J Cancer Res, 87(1): 98-104 , 1996
12 Ishikura S., Mitsumori M., Hiraoka M.: Clinical results of breast conserving therapy for stage I and II breast cancers: assessment of local recurrence in relation to surgical margins., Int. J. Clin. Oncol., 1: 170-75, 1996
13 Shibata T., Shibamoto Y., Sasai K., Oya N., Murata R., Takagi T., Hiraoka M. , Takahashi M., Abe M.: Tirapazamine: hypoxic cytotoxicity and interaction with radiation as assessed by the micronucleus assay., Br J Cancer Suppl, 27: S61-4, 1996
14 Harauchi H., Umeda T., Inamura K., Teshima T., Inoue T., Hishikawa Y., Ando Y., Fukuhisa K., Nagata Y., Okajima K., Murakami M.: Initial Data-element Selection and its Feasibility for the Development of a Multi-institutional Radiation Oncology Database., J. Jpn. Soc. Ther. Radiol. Oncol., 8: 335-45, 1996
1995
1 Hiraoka M., Mitsumori M., Okajima K., Okuno Y., Matsui K., Nakata M., Nagata Y., Takahashi M., Abe M.: Clinical results of breast-conservation therapy using a CT simulator., Gan To Kagaku Ryoho, 22(Suppl 3): 237-43, 1995
2 Hiraoka M., Nishimura Y., Masunaga S., Koishi M., Mitsumori M., Y.P. Li, Nagata Y., Akuta K., Takahashi M., Abe M.: Clinical evaluation of 430 MHz microwave hyperthermia system with lens applicator for cancer therapy., Med Biol Eng Comput, 33(1): 44-7, 1995
3 Hiraoka M., Nishimura Y., Nagata Y., Mitsumori M., Okuno Y., P.Y. Li, Takahashi M., Masunaga S., Akuta K., Koishi M., et al.: Clinical results of thermoradiotherapy for soft tissue tumours., Int J Hyperthermia, 11(3): 365-77, 1995
4 Murata R., Nishimura Y., Hiraoka M., Abe M., Satoh M.: Manganese chloride treatment does not protect against acute radiation injury of skin or crypt cells., Radiat Res, 143(3): 316-9, 1995
5 Nagata, Y., Hiraoka M., Nishimura Y., Masunaga S., Akuta K., Y.P. Li, Koishi M., Mitsumori M., Okuno Y., Takahashi M., et al.: Clinical experiences in the thermoradiotherapy for advanced gastric cancer., Int J Hyperthermia, 11(4): 501-10, 1995
6 Nishimura Y., Hiraoka M., Mitsumori M., Okuno Y., Y.P. Li, Masunaga S., Koishi M., Akuta K., Abe M.: Thermoradiotherapy of superficial and subsurface tumours: analysis of thermal parameters and tumour response., Int J Hyperthermia, 11(5): 603-13, 1995
7 Nagata Y., Okajima K., Murata R., Mizowaki T., Yamamoto S., Mitsumori M., Nishimura Y., Hiraoka M., Nishidai T., Nakata M., Abe M., Shibamoto Y., Takahashi M.: Development of the CT simulator and evaluation of its clinical efficacy., J. Jpn. Soc. Ther. Radiol. Oncol., 7: 65-75, 1995
8 Ohtsu S., Miyakoshi J., Tsukada T., Hiraoka M., Abe M., Takebe H.: Enhancement of beta-galactosidase gene expression in rat pheochromocytoma cells by exposure to extremely low frequency magnetic fields., Biochem Biophys Res Commun, 212(1): 104-9, 1995
1994
1 Masunaga S., Hiraoka M., Akuta K., et al.: Phase I/II trial of preoperative thermoradiotherapy in the treatment of urinary bladder cancer., Int. J. Hyperthermia, 10(1): 31-40, 1994
2 Ikenaga M., Ohura , Hiraoka M. et al.: Hyperthermic treatment of canine tibia through RF inductive heating of an intramedullary nail:a new experimental approach to hyperthermia for metastatic bone tumours., Int. J. Hyperthermia, 10(4): 507-16, 1994
3 Hiraoka M., Kodama H., Mitsumori M., et al.: Preliminary results of quadrantectomy and radiation therapy for breast cancer., Breast Cancer, 1(2): 117-22, 1994
4 Hiraoka M., Mitsumori M., Okajima K., et al.: Use of a CT simulator in radiotherapy treatment planning for breast conserving therapy., Radioth. Oncol., 33(1): 48-55, 1994
5 Hiraoka M., Nishimura Y., Nagata Y., et al.: Site-specific phase I,II trials of hyperthermia at Kyoto University., Int. J. Hyperthermia, 10(3): 403-10, 1994
6 Nishimura Y., Ono K., Tsutsui K., Oya N., Okajima K., Hiraoka M., Abe M.: Esophageal cancer treated with radiotherapy: impact of total treatment time and fractionation., Int J Radiat Oncol Biol Phys., 30(5): 1099-105, 1994
7 Nagata Y., Okajima K., Murata R., Mitsumori M., Mizowaki T., Tsutsui K., Ono K., Nishimura Y., Hiraoka M., Nishidai T., et al.: Three-dimensional treatment planning for maxillary cancer using a CT simulator., Int J Radiat Oncol Biol Phys., 30(4): 979-83, 1994
8 Mitsumori M., Hiraoka M., Shibata T., Okuno Y., Masunaga S., Koishi M., Okajima K., Nagata Y., Nishimura Y., Abe M., et al.: Development of intra-arterial hyperthermia using a dextran-magnetite complex., Int J Hyperthermia, 10(6): 785-93, 1994
9 Matsumoto M., Yoshimura N., Honda Y., Hiraoka M., Ohura K.: Ferromagnetic hyperthermia in rabbit eyes using a new glass-ceramic thermoseed., Graefes Arch Clin Exp Ophthalmol.,232(3): 176-81, 1994
1993
1 Kikuchi M., Amemiya S.,Hiraoka M., et al.: Guide to the use of hyperthermic equipment. 1. Capacitively-coupled heating., Int. J. Hyperthermia, 9(2): 187-203, 1993
2 Nagata Y., Ishigaki T., Okajima K., Fujiwara K., Kinashi T., Mitumori M., Ooya N., Kitakabu Y., Hiraoka M., Abe M., et al.: Transcatheter arterial infusion therapy combined with radical hysterectomy in the treatment of advanced cervical cancer., Cardiovasc Intervent Radiol., 16(1): 14-8; discussion 18-20, 1993
3 Kikuchi M., Amemiya Y., Egawa S., Onoyama Y., Kato H., Kanai H., Saito Y., Tsukiyama I., Hiraoka M., Mizushina S., et al.: Guide to the use of hyperthermia equipment. 2. Microwave heating. The Japanese Society of Hyperthermic Oncology., Int J Hyperthermia, 9(3): 341-60, 1993
4 Kikuchi M., Amemiya Y., Egawa S., Onoyama Y., Kato H., Kanai H., Saito Y., Tsukiyama I., Hiraoka M., Mizushina S., et al.: Guide for the protection of occupationally-exposed personnel in hyperthermia treatment from the potential hazards to health., Int J Hyperthermia, 9(4): 613-24, 1993